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ABSTRACT 
Osteoporosis is a serious health issue affecting 10 million Americans, with an 
additional 44 million being at risk.  Due to the morbidity and mortality associated with 
fractures caused by osteoporosis, it is an important public health concern.  Some 
researchers suggest that African-American women fracture at a lower rate when 
compared to Caucasians with the same bone mineral density (BMD).  However, when 
African-American women do fracture, they have higher mortality and morbidity rates.  
Data regarding risk factors and prevalence of low BMD among African American and 
Caucasian college-aged women are limited.  Purpose:  The primary purpose of this 
research was to explain the variance in bone mineral density (BMD) in African-American 
and Caucasian college-aged women.  A secondary purpose was to evaluate the 
differences in osteoporosis knowledge among college-aged African-American and 
Caucasian women.  Methodology:  This study included 101 women ages 18 to 30 
years.  Fifty participants were African-American and 51 were Caucasian.  
Anthropometric measurements, osteoporosis knowledge, bone mineral density, body 
composition, physical activity and nutrient intake were assessed in the present study.  
Results:  In this sample, 38.6% had low spinal BMD and 7.9% had low femoral bone 
mineral density.  Femoral and spinal BMD were regressed on seven potential 
predictors:  race, family history of osteoporosis, weight, current physical activity, 
osteoporosis knowledge, length of time on oral contraceptives, and calcium intake.  
Multiple regression analysis showed that BMI/weight and current physical activity were 
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the only two independent variables that significantly predicted spinal and femoral BMD.  
The final model explained 14.9% of the variance in spinal BMD and 13.1% of the 
variance in femoral BMD.  Osteoporosis knowledge was not significantly different 
between African-Americans and Caucasians.  Conclusions:  Contrary to what was 
hypothesized, race was not a significant predictor of spinal or femoral BMD.  Therefore, 
it is important for both African-American and Caucasian women alike to engage in 
osteoporosis-preventive behaviors.  If women between the ages of 18 and 30 are made 
aware of their low-BMD status, they can begin bone-building activities before they reach 
peak bone mass.  This provides an opportunity to decrease risk for osteoporosis and 
related fractures later in life.   
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Chapter I 
 
Introduction 
 
Osteoporosis is defined as a skeletal disorder characterized by compromised 
bone strength, predisposing a person to an increased fracture risk (National Institutes of 
Health, 2001).  The term “osteoporosis,” which literally means “porous bone,” was 
coined by French pathologist Jean Georges Chretien Frederic Martin Lobstein in the 
1830s to describe patients’ bones that had larger than normal holes (Patlak, 2001).  
Osteoporosis was not officially recognized as a disease by the World Health 
Organization (WHO) until 1994--over a century after it was first described (Anderson 
and Delmas, 2002).   
It is estimated that 10 million Americans have osteoporosis, while 44 million 
adults over the age of 50 years are estimated to be at risk for this disease (Thomas, 
2007).  It is projected that by the year 2020, osteoporosis will affect approximately 14 
million adults over the age of 50 (Lane, 2006).  Women account for 80% of those 
affected by osteoporosis; and, men account for the remaining 20% (National 
Osteoporosis Foundation [NOF], 2008).  As a result of the higher prevalence of 
osteoporosis in women, their risk of hip fractures is equal to their risk of breast, uterine, 
and ovarian cancers combined (Thomas, 2007).   
Due to the morbidity and mortality associated with fractures caused by 
osteoporosis, it is an important public health concern (Thomas, 2007).  The 
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annual incidence of osteoporotic fractures is estimated at over 1.5 million in the United 
States with 1 in 5 persons dying during the first year following a hip fracture (Lane, 
2006).  Some factors associated with increased mortality following a hip fracture include 
preexisting chronic conditions and low physical ability in patients prior to hip fracture 
(Meyer, Tverdal, Falch, and Peders, 2000).  Hip fractures are considered the most 
serious kind of fracture due to the cost, mortality, and morbidity associated with them 
(Cummings and Melton, 2002).  In 2005, hip fractures accounted for 72% of the 
estimated $17 billion spent on osteoporotic fractures in the United States (Burge et al., 
2007).  The medical cost of osteoporosis-related fractures is projected to rise nearly 
50% by the year 2025 (Burge et al., 2007).  Fifty to 70% of older patients are not able to 
return to their prefracture level of functioning; and, up to 79% of older patients are 
unable to ambulate following a hip fracture (Coleman et al., 2000). 
When examining the mortality and morbidity statistics associated with 
osteoporotic fractures, studies show that certain ethnic groups are affected 
disproportionally.  Barrett-Connor et al. (2005) suggest that Black women fracture at a 
lower rate when compared to Caucasians with the same bone mineral density; but, 
when they do fracture they have higher mortality and morbidity rates.  These differences 
in outcome, in part, can be attributed to racial disparities in screening and treatment of 
Blacks at risk for osteoporosis.  Neuner et al. (2007) found that Black female Medicare 
recipients aged 65-89 years, who resided in Florida, Illinois, or New York, were about 
2/3 less likely than Whites to undergo BMD testing.  Moreover, after surveying Black 
and White women aged 50 years and older who received their health care coverage 
through a large regional managed care organization in Alabama, Mudano et al. (2003) 
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found that Black women had roughly a two-third lower odds than White women of 
receiving BMD testing and all forms of prescription osteoporosis, even after having a 
previous fracture.  Miller et al. (2005) found that the odds of at-risk Black women being 
referred for bone density testing were 61% lower than that of White women of 
comparable risk.  Physicians were also less likely to recommend calcium and vitamin D 
supplementation to at-risk Blacks in comparison to White women of comparable risk 
(Miller et al., 2005). 
The number of osteoporotic fractures is projected to increase an estimated 2.5 
million by the year 2025 with African American women accounting for 3.2 % of the 
increase (Vanness and Tosteson, 2005).  This is mainly due to the growing elderly 
population in the United States.  By the year 2030 in the United States, ethnic minorities 
will comprise 25% of the 65 and older population (Bohannon, 1999).  Annually, about 
500,000 hospitalizations, 800,000 emergency room visits, and 180,000 nursing home 
placement can be attributed to osteoporotic fractures (US Department of Health and 
Human Services [USDHHS], 2004).     
 
BMD and Fracture Risk 
 There is a strong relationship between BMD and fracture risk in postmenopausal 
women.  In postmenopausal White women, there is a 1.5 to 2.6-fold increase in relative 
fracture risk for every one standard deviation decrease in BMD (Siris et al., 2001).  
However, this relationship is unclear in premenopausal women (Gourlay and Brown, 
2004).  Furthermore, there are limited data on the relationship between BMD and 
fracture risk in non-Caucasian women.  Moreover, the data that exists are difficult to 
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interpret (Binkley, Schmeer, Wasnich, Lenchik, 2002).  Some researchers recommend 
not using the word “osteoporosis” in conjunction with premenopausal women in cases 
where the diagnosis is based solely on BMD, when values are at the low end or just 
below normal BMD values, and when no fractures have occurred in the past (Cohen 
and Shane, 2008).  The International Society for Clinical Densitometry (ISCD) goes 
even farther and states that the WHO classification for normal, osteopenia, and 
osteoporosis is not appropriate for healthy premenopausal women (Lewiecki, 2005).  
Below normal BMD values in young adults are typically not an important concern due to 
their low risk of falls and their greater muscle strength and agility (Gourlay and Brown, 
2004).  However, a history of premenopausal fractures increases risk of 
postmenopausal fractures (Hosmer, Genant, and Browner, 2002).  Bone mineral density 
acquired by early adulthood can explain 60% of osteoporosis risk (Bachrach, Hastie, 
Wang, Narasimhan, and Marcus, 1999).  Therefore, attainment of high peak bone mass 
can greatly reduce osteoporosis and associated fracture risk. 
 
T-score and Z-score 
The skeleton consists of cortical bone and trabecular bone.  Cortical bone, which 
forms the outer part of long bones, is very dense and calcified, whereas trabecular 
bone, located at the ends of long bones and in the spine, is more spongy in appearance 
(K. Khan et al., 2001).  Trabecular bone has a higher rate of bone turnover in 
comparison to cortical bone, which makes it more susceptible to bone loss (Hochberg et 
al., 2002).  More than 50% of the bone in the lumbar spine and in the trochanter of the 
femur is trabecular bone, which makes these sites more susceptible to fracture (Meier, 
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et al., 2004).  Increased tendency to falls is also a reason why postmenopausal women 
are at increased risk for hip fractures (Geusens et al., 2002).   
The utilization of t-scores and z-scores to express bone mineral density (BMD) is 
typical.  The t-score is based on comparison of an individual’s bone density to the bone 
density of a 25- to 30-year-old of similar gender and race/ethnicity (Winters-Stone, 
2005, p. 10).  Calculation of an individual’s t-score is performed by using the formula:  
(patient’s BMD – young normal mean)/SD of young normal.  The individual’s BMD is 
compared with the mean value in a population of similar age, sex, and height when 
using the z-score (Richmond, 2003).  Calculation of an individual’s z-score is performed 
by using the formula:   (patient's BMD – mean of similar population) / SD of similar 
population.  Diagnostic criteria for osteoporosis, which is based on an individual’s 
BMD t-scores, were established by the WHO (Lane, 2006).  The WHO (1994) uses a 
threshold of 2.5 standard deviations below the mean of young adult women and a 
threshold of 1 to 2.5 standard deviations below the mean of young adult women as the 
criterion for a diagnosis of osteoporosis and osteopenia, respectively.  These definitions 
for osteoporosis and osteopenia, however, are based on BMD measurements in 
menopausal White women.  Furthermore, applying these criteria to premenopausal 
women with low BMD was not the original intention of these definitions (A. Khan, 2006).  
Questions have been raised as to whether or not separate race-specific norms should 
be used to define osteoporosis and osteopenia in non-White groups (Acheson, 2005).  It 
is suggested that z-scores, instead of t-scores, be used when examining the BMD of 
premenopausal women, children, and men younger than 20 years (Lewiecki et al., 
2004).  Furthermore, the use of z-scores is suggested when determining the BMD of 
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African Americans on scanners that do not have an African-American reference 
database (Richmond, 2003).  For the present study, t-scores were utilized for four 
reasons:  1) t-scores and z-scores are relatively equal for individuals between the ages 
of 19 and 30 years, 2) the densitometer utilized for this study contains an African-
American database, 3) t-scores rather than z-scores are utilized by the WHO for 
diagnostic criteria, 4) and z-scores are not available on the densitometer used in this 
study for individuals younger than 18 years. 
 Bone densitometry, which is used to measure BMD, is one of the most frequently 
used techniques in the assessment and management of patients suspected to have 
osteoporosis (Ralston, 2005).  Several techniques exist that can measure BMD.  They 
include single-photon absorptiometry, dual-photon absorptiometry, dual-energy x-ray 
absorptiometry (DEXA), and quantitative computed tomography (Sievanen, Oja, and 
Vuori, 1992).  DEXA, however, is considered the gold standard of methods used to 
diagnose osteoporosis (Lochmuller, Muller, Kuhn, Lill, and Eckstein, 2003).  It delivers a 
dose of radiation that is about one tenth of that delivered by a standard chest x-ray 
(Vega, de Tejada, Hachero, Cano, and Rodriguez, 1996).  Current DEXA technology 
uses a fan-beam x-ray source coupled with multi-element solid-state detectors 
(Salamone et al., 2000).  This results in increased resolution and scan speed.  
 
Risk Factors 
       Risk factors for osteoporosis can be classified as either primary or secondary.  
Primary risk factors for osteoporosis include estrogen deficiency, age, being female, 
genetic factors, personal history of fractures in the absence of trauma, thin/small frame, 
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diet low in calcium, vitamin D deficiency and reaching menopause either naturally or 
surgically before the age of 45 (Amonkar and Mody, 2002).  In addition to those listed, 
the NOF (2008) also lists diseases and conditions such as anorexia nervosa, 
rheumatoid arthritis, and gastrointestinal diseases as well as being of Caucasian, Asian, 
or Hispanic/Latino race/ethnicities as risk factors for osteoporosis.  Secondary risk 
factors include the use of certain drugs such as glucocorticoids and antiepileptics and 
lifestyle behaviors such as excessive alcohol consumption, smoking and physical 
inactivity (Amonkar and Mody, 2002).  Just as risk factors can be considered primary or 
secondary, osteoporosis can be classified as either primary osteoporosis or secondary 
osteoporosis.  Primary osteoporosis is defined as bone loss that occurs during the 
normal human aging process while secondary osteoporosis is defined as bone loss that 
results from specific, well-defined clinical disorders (Fitzpatrick, 2002). 
 The U.S. Preventive Services Task Force (as cited by USDHHS, 2004) 
recommends routine osteoporosis screening for all women aged 65 and older and 
starting at age 60 for women who are at high risk for osteoporosis as a result of having 
a body weight less than 70 kg or having a lack of hormone replacement therapy.  The 
Task Force, however, does not make any BMD testing recommendations for 
premenopausal women nor are their screening recommendations race-specific.  This 
poses a problem since it is possible for premenopausal women and non-White women 
to develop low BMD.  The Institute for Clinical Systems Improvement, however, 
recommends BMD testing for premenopausal women who have had amenorrhea for 
more than 1 year (Mauck and Clarke, 2006).   
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Approximately 15% of premenopausal women have osteopenia (Kanis, Delmas, 
Burckhardt, Cooper, and Torgerson, 1997).  Some factors that are linked to low bone 
mineral density in premenopausal women include conditions that require the use of 
glucocorticoids and anticonvulsants and the eating disorder, anorexia nervosa (Hansen 
and Vondracek, 2004).  Other factors that are linked to low BMD in premenopausal 
women are delayed menarche and amenorrhea (Gourlay and Brown, 2004).   
 
Prevention and Treatment 
 The NOF (2008) lists 5 steps for bone health and the prevention of osteoporosis:  
(1) get recommended amounts of calcium and vitamin D daily, (2) engage in regular 
weight-bearing exercises, (3) avoid smoking and excessive alcohol consumption, (4) 
discuss bone health with your healthcare provider, and (5) have a bone density test and 
take medication when appropriate.  Several pharmacological and non-pharmacological 
interventions exist for the treatment of osteoporosis.  The purpose of the 
pharmacological interventions is either to inhibit bone resorption and/or to decrease 
bone loss.  Bisphosphonates, calcitonins, estrogens and the selective estrogen receptor 
modulators and calcium are the 5 major pharmacological categories of drugs used to 
treat osteoporosis (Stafford, Drieling, and Hersh, 2004).  Bisphosphonates are the drug 
of choice with one study showing that they were prescribed 73% of the time during 
osteoporosis patients’ visits (Stafford, Drieling, and Hersh, 2004).  Non-pharmacological 
treatments include weight-bearing exercise, hip protectors, pain management, 
rehabilitation to improve mobility, ortheses, back supports and walking aids (Gaudio and 
Morabito, 2005; Lips and Ooms, 2000).  Improvement of mobility is important because it 
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reduces fall-risk.  A reduction in fall-risk is important because, a fall from standing height 
or less is the cause of approximately 90% of hip fractures in both men and women 
(Cummings and Melton, 2002).  
 Although bisphosphonates are the drug of choice for treating osteoporosis, data 
are limited regarding the use of these drugs in premenopausal women who do not have 
a secondary cause of bone loss, such as glucocorticoid therapy or an overactive thyroid 
gland (A. Khan, 2006).  Glucocorticoid therapy causes an increase in bone turnover.  
Bisposphonates are beneficial in women who have undergone this type of therapy 
because they work by lowering bone turnover (A. Khan, 2006).  These drugs, however, 
could suppress normal bone turnover rates in women who do not have a secondary 
cause of bone loss (A. Khan, 2006).  Another reason why bisphosphates are not 
typically prescribed to premenopausal women with secondary causes of bone loss is 
because they have the ability to be discharged from the bones several years after being 
ingested (A. Khan, 2006).  This gives them the potential of being released during 
pregnancy; and their effects on the bones of fetuses are unknown (A. Khan, 2006). 
 In order to understand how pharmacological treatments for low bone density 
work, the process of bone building and bone resorption must be understood.  Bone 
contains three types of cells:  osteoblasts, osteocytes, and osteoclasts (K. Khan, et al., 
2001).  Osteoblasts, which are under the control of endocrine, paracrine, and autocrine 
factors, are responsible for producing bone matrix.  Osteocytes are mature bone cells 
that assist with communication between bone cells and aid in bones response to 
mechanical loading.  Lastly, osteoclasts are responsible for removing old bone.  One 
way in which antiresorptive pharmacological agents affect bone cells is by shortening 
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the lifespan of osteoclasts and increasing the lifespan of osteocytes and osteoblasts 
(Boonen, Haentjens, Vandenput, and Vanderschueren, 2004). 
 
Purpose: 
The primary purpose of this research is to explain the variance in BMD in African-
American and Caucasian college-aged women.  A secondary purpose was to evaluate 
the differences in osteoporosis knowledge among college-aged African-American and 
Caucasian women. 
 
Research question: 
What variables account for the variance in BMD among African-American and 
Caucasian college-aged women? 
 
Operational Definitions: 
 Amenorrhea is defined as the absence or suppression of menstruation 
(Thomas, 1997). 
Anticonvulsant is defined as an agent that prevents or relieves the sudden 
onset of involuntary muscular contractions and relaxations (Thomas, 1997). 
Anorexia nervosa is defined as an eating disorder marked by excessive fasting 
(Thomas, 1997). 
Bone matrix is a combination of extracellular proteins arranged to promote 
mineral deposition (Marzia et al., 2000). 
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Cortical bone is a very dense and calcified type of bone found on the outer parts 
of long bones, such as the femur (K. Khan et al., 2001). 
Glucocorticoid is defined as a general classification of adrenal cortical 
hormones that are primarily active in protecting against stress and in affecting protein 
and carbohydrate metabolism (Thomas, 1997). 
Menarche (menses) is defined as the initial menstrual period in a woman which 
usually occurs between the ages of 9 and 17 years (Thomas, 1997). 
Osteoblasts are bone cells responsible for producing bone matrix (K. Khan, et 
al., 2001, ch. 1). 
Osteoclasts are bone cells that are responsible for the removal of old bone (K. 
Khan et al., p. 7, 2001). 
Osteocytes are mature bone cells that assist with communication between bone 
cells and aid in bones response to mechanical loading (K. Khan, et al., 2001, ch. 1). 
Peak bone mass is defined as the maximum amount of bone acquired at the 
end of growth (Lafage-Proust, Combe, Barthe, and Aparicio, 1999). 
Premature menopause refers to development of amenorrhea due to cessation 
of ovarian function before the age of 40 years (Goswami and Conway, 2005). 
Premenopausal or premenopause refers to the period in women between the 
age of peak bone mass and menopause (Lewiecki, 2004). 
Trabecular bone is located at the ends of long bones and in the spine, is spongy 
in appearance (K. Khan et al., 2001). 
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Null Hypotheses: 
HO1:  African-American women’s bone mineral density level will not be  
significantly different from Caucasian women’s bone mineral density among low, 
normal, and high BMI groups. 
HO2:   Women with high BMIs will not have significantly different bone mineral  
 density than women with low BMIs regardless of ethnicity. 
HO3:  Women who have inadequate intake of calcium will not have a significantly 
different BMD than women who have an adequate intake of calcium.   
HO4:   BMD will not be significantly different in women who currently engage in  
 regular physical activity in comparison to women who do not engage in  
 regular physical activity regardless of ethnicity. 
HO5: Women who participated in high school sports will not have significantly different 
BMD values than women who have not engaged in physical activity in the past 
regardless of ethnicity. 
HO6: Length of time on oral contraceptives will not be significantly related BMD.  
HO7: BMD values will not be significantly different in women who are more 
knowledgeable of osteoporosis in comparison to those who are less 
knowledgeable. 
HO8: BMD values will not be significantly different between African American and 
Caucasian women. 
 
 
Alternative Hypotheses: 
HA1:  African-American women’s bone mineral density level will be significantly  
 different than Caucasian women’s bone mineral density among low, 
 normal, and high BMI groups. 
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HA2:   Women with high BMIs will have significantly different bone mineral density than 
women with low BMIs regardless of ethnicity. 
HA3:   Women who have inadequate calcium intake will have a significantly different 
BMD than women who have an adequate intake of calcium.  
HA4:   BMD will be significantly different in women who currently engage in regular 
physical activity in comparison to women who do not engage in regular physical 
activity regardless of ethnicity. 
HA5: Women who participated in high school sports will have  
 significantly different BMD values than women who have not engaged in  
 physical activity in the past regardless of ethnicity. 
HA6: Length of time on oral contraceptives will be significantly related to BMD.  
HA7: BMD values will be significantly different in women who are more knowledgeable 
of osteoporosis in comparison to those who are less knowledgeable. 
HA8: BMD values will be significantly different between African American and 
Caucasian women. 
 
 
 
Delimitations: 
 
1. Only African-Americans and Caucasians are included in this study. 
 
2. Only women are included in this study. 
 
3. Participants must be between the ages of 18 and 30, inclusive. 
 
 
Limitations: 
 
1. All participants will be volunteers.  Volunteers are likely to represent a biased 
sample because of their interest and motivation to volunteer. 
2. The sample of this study will not be a random sample. 
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3. The sample of this study will be selected from Northern Mississippi and therefore 
not a nationally representative sample. 
 
 
Assumptions: 
1. Participants can read and understand English. 
2. Participants are the race that they report. 
3. Participants answer questions honestly. 
 
 
Significance of Study: 
With an increasing aging population and longevity of minority groups, 
osteoporosis is increasing as a public health concern (Kidambi, Partington and Binkley, 
2005).  Some researchers suggest that African American women fracture at a lower rate 
when compared to Caucasians with the same bone mineral density but when they do 
fracture they have higher mortality and morbidity rates (Barrett-Connor et al., 2005).  
Data regarding risk factors and prevalence of low bone mineral density among African 
American college women are limited.  Caucasian women are at the greatest risk for low 
BMD.  However, African American women do have osteopenia and osteoporosis.  The 
primary objective of this research is to explain the variance in BMD in African-American 
and Caucasian college-aged women.  A secondary objective of this study is to evaluate 
knowledge about osteoporosis among college-aged African-American and Caucasian 
women. 
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Chapter II 
 
Review of Literature 
 This chapter contains an extensive review of literature pertinent to the aims of 
this study.  This chapter is divided into eight sections.  The first section discusses peak 
bone mass and the importance of attaining this early in life.  The second section 
explains risk factors of osteoporosis.  The third section, which is arguably the most 
important section, discusses racial differences in BMD and osteoporosis risk.  The 
fourth section discusses heredity and how it can play a part in determining osteoporosis 
risk.  The fifth section discusses nutrient intake and its importance in BMD 
determination.  The sixth section discusses contraceptive use and its effect on bone 
mineral density.  The seventh section discusses body composition and body weight and 
their possible effect on BMD.  The eighth section discusses the importance of type of 
physical activity for building or maintaining BMD.  Lastly, the ninth section discusses 
osteoporosis knowledge. 
 
Peak Bone Mass 
 Amount of peak bone mass is a major determinant of osteoporosis and fractures 
in the elderly (Wren, Kim, Janicka, Sanchez, and Gilsanz, 2007).  According to Thomas 
(2007), the most important predictor of future fracture risk is peak bone mass.  Bone 
mineral density acquired by early adulthood can explain 60% of osteoporosis risk 
(Bachrach et al., 1999).  Peak bone mass is defined as the maximum amount of bone 
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acquired at the end of growth (Lafage-Proust et al., 1999).  It is generally thought that 
women reach peak bone mass in their mid-to-late 20s (Picone, 2004).  Other 
researchers, however, report BMD peaking at around age 35 years (Cohen and Roe, 
2000). 
Many factors play a role in the attainment of peak bone mass.  These factors 
include genetics, nutrition, and exercise in addition to other factors such as tobacco and 
alcohol use (Heaney et al., 2000).  Ettinger et al. (1997) reports that Black women and 
men attain 5-15% more peak bone mass than Whites.  Heredity, nutrition, and exercise 
will be discussed in a later section.   
 
Risk Factors 
   Primary risk factors for osteoporosis include estrogen deficiency, age, being 
female, genetic factors, thin/small frame, diet low in calcium, vitamin D deficiency, being 
of Caucasian, Asian, or Hispanic/Latino race/ethnicities and reaching menopause either 
naturally or surgically before the age of 45 (Amonkar and Mody, 2002; NOF, 2008).  
The risk of bone loss and osteoporosis increases with age due to increased bone 
resorption and decreased bone formation which is a result of the decrease in estrogen 
production (Leskela et al., 2003).  Women who reach menopause prematurely are at 
greater risk for osteoporosis due to their extended time of estrogen deficiency 
(Kalantaridou et al., 2006).  Estrogen deficiency induces bone loss by causing the 
upregulation of osteoclasts (Cencil et al., 2000).   
 Although most prevention and research protocols with osteoporosis are mainly 
designed with the underlying school of thought that African-American and Hispanic 
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women have a small chance of developing osteoporosis, these minority groups are 
disproportionately affected by some of the main risk factors associated with 
osteoporosis (Geller and Derman, 2001).  Results from NHANES III show that African 
American women tend to have a lower intake of calcium when compared to White and 
Hispanic women (Arab, Carriquiry, Steck-Scott, and Gaudet, 2003).   
Sex hormones play a role in the differences in BMD among men and women.  
Androgens, which are male sex hormones, are thought to increase bone formation 
(Orwoll, Belknap, and Klein, 2001).  Due to these hormonal differences, women typically 
have a smaller/thinner frame than men.  Consequently, as a result of their bone 
geometry, individuals with small frames are at risk for osteoporosis due to weaker 
bones (Lewiecki, 2004).  Women are also at greater risk for osteoporosis than men 
because they begin with a lower amount of bone mass than men and because they lose 
bone mass at a greater rate than men (USDHHS, 2004).   
Secondary risk factors include the use of certain drugs such as glucocorticoids 
and antiepileptics and lifestyle behaviors such as excessive alcohol consumption, 
smoking, anorexia nervosa, rheumatoid arthritis, and gastrointestinal diseases and 
physical inactivity (Amonkar and Mody, 2002; NOF, 2008).  Glucocorticoids cause 
osteoporosis by influencing the production and action of hormones that regulate bone 
and calcium metabolism, which in turn causes bone resorption and impaired bone 
formation (Mazziotti, Angeli, Bilezikian, Canalis, and Giustina, 2006).  Long-term 
treatment with antiepileptics can ultimately result in vitamin D deficiency, which 
increases risk of osteoporosis (Ma, Kong, Chan, Tong, and Chan, 2007).   
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Race 
 The NOF (2008) states that individuals who are Caucasian, Asian, or 
Hispanic/Latino are at increased risk for osteoporosis.  When compared to Caucasians, 
as well as other ethnicities, African American women tend to have higher BMD values 
(USDHHS, 2004 and NIH, 2001).  Barrett-Conner et al. (2005) described the prevalence 
of low BMD and the relationship between low BMD and 1-year fracture occurrence in 
Black, Asian, White, Hispanic, and Native American postmenopausal women 50 years 
or older.  Results show that Black women had the highest mean t-score, whereas, Asian 
women had the lowest mean t-score.  It was also found that White and Hispanic women 
had the greatest risk for fractures and that Asian women had the lowest risk for 
fractures, although Asian American women have lower BMD values (Barrett-Conner et 
al, 2005).  Finkelstein et al. (2002) also found that African-American women between 
the ages of 42 to 52 years old had higher BMD values in the femoral neck and lumbar 
spine when compared to Caucasian, Chinese, and Japanese women. 
 Differences in BMD between races in young adults have been tested as well.  
Ettinger et al. (1997) tested whether or not differences in bone density between Black 
and White males and females between the ages of 25-36 years can be explained by 
differences in bone metabolism and lifestyle.  Their results show that both male and 
female Blacks had significantly higher BMDs at all skeletal sites in comparison to White 
males and White females.    
 Though studies continuously show that African Americans have higher BMD than 
other ethnic groups, this does not mean that African Americans are without risk 
regarding osteoporosis.  Currently, over 300,000 African-American women have 
 19 
 
osteoporosis (Kessenich, 2000).  Results from the National Osteoporosis Risk 
Assessment (NORA), a longitudinal observational study examining the incidence, risk 
factors, and fracture incidence of low BMD in postmenopausal women showed that 32% 
of African-American women had osteopenia and 4% had osteoporosis (Siris et al., 
2001).  Moreover, Kidambi, Partington and Binkley (2005) found that when examining 
the quantitative calcaneal ultrasound results of 150 Wisconsin, African-American 
women aged 45 years and older, 33% had low bone mass.  Additionally, only 25% of 
the study sample surveyed believed that they were at moderate to high risk for 
osteoporosis. 
 
Heredity 
 The NOF (2008) lists family history as a risk factor for osteoporosis.  It is believed 
that a variety of genes that control bone building and bone loss are involved in the 
development of osteoporosis (Rizzoli, Bonjour, and Ferrari, 2001).  The determinants of 
bone strength, including BMD, peak bone mass, bone geometry, and bone metabolism, 
are influenced by genetics (Bohannon, 1999).  Up to 80% of the differences seen in 
peak BMD can be attributed to genetic factors (Koller et al., 2000).  Hip fractures are 
twice as likely to occur in women with a maternal history of hip fracture in comparison to 
women without a maternal history of hip fracture (Lane, 2006). 
 
Nutrient Intake 
 The bones and teeth house over 99% of total body calcium in humans 
(Cashman, 2002).  According to the NOF (2008), a diet low in calcium is a risk factor for 
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osteoporosis.  Although heredity can contribute up to 80% of the differences seen in 
peak BMD, up to 40% of the variability seen in peak bone mass can be attributed to 
environmental factors, including diet (Koller et al., 2000; Lewiecki, 2005).  Some of the 
vitamins that are shown to have an effect, whether substantial or negligible, include 
calcium, vitamin D, iron, zinc, and magnesium.  A deficiency in magnesium can affect 
bone density indirectly.  Calcium metabolism is altered when there is a deficiency in 
magnesium (Ilich and Kerstetter, 2000).  Dairy product intake is a measure of calcium 
intake due to the abundance of calcium in dairy products; especially milk (Heaney, 
2000).  Food frequency questionnaires are commonly used to measure dietary intake in 
research studies due to the low cost associated with their use (Sebring et al., 2007). 
Although the recommended dietary reference intake (DRI) for calcium is 1300 mg 
for individuals ages 9 to 18 and 1000 mg for individuals ages 19 to 50, only 19% of 
females ages 9 to 18 and 40% of women ages 19 to 50 are currently meeting these 
requirements (Beaudoin and Blum, 2005).  The percentages of females not meeting the 
DRI are even higher when examining minority populations.  Lactose maldigestion’s high 
prevalence among minority groups, especially non-Hispanic African Americans, is 
typically cited as the culprit for low intake among minority populations (Jackson and 
Savaiano, 2001).  Lactose maldigestion occurs in 70% to 75% of Blacks (Buchowski, 
Semenya, and Johnson, 2002).  Some evidence exists that there is an increased 
prevalence of osteoporosis among lactose maldigestors due to their avoidance of dairy 
products (Jackson and Savaiano, 2001). 
 The effect that calcium has on bone density and fracture risk has been debated.  
One study found that higher intakes of vitamin D and calcium reduced osteoporosis risk 
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but not 3-year fracture risk in Caucasian women (Nieves et al., 2008).  Another study 
conducted in Sweden showed that calcium and vitamin D intake in women estimated at 
middle age and older age is not of major importance in the primary prevention of 
osteoporotic fractures (Michaelsson, Melhus, Belloco, and Wolk, 2003).  Wallace and 
Ballard (2002) found that lifetime calcium consumption was not a significant predictor of 
BMD or bone mineral content (BMC) in premenopausal Caucasian women, although 
current calcium consumption contributed to the total variance in BMD.  Prince et al. 
(2006), however, found that supplementation with 1200 mg of calcium carbonate tablets 
in elderly women reduced the risk of clinical fracture in those who adhered to the 
protocol.  According to Heaney (2001), osteoporotic fracture risk can be reduced by 
30% to 50% by increasing calcium intake in the over-65 population.  Ramsdale et al. (as 
cited in Gourlay and Brown, 2004) found a significant correlation between calcium 
intake and BMD at the neck of the femur (r = .41), the Ward’s triangle of the femur (r = 
.40) and the trochanter of the femur (r = .47) and at the spine (r = .27) in healthy 
premenopausal women aged 21 to 47 years.  Harris et al. (2003) also found that 
calcium, magnesium, phosphorus, zinc and vitamin D had positive significant 
associations with BMD. 
   
Contraceptives 
 Some evidence exists that the use of oral contraceptives by women decreases 
the risk of osteoporosis.  A study of 710 Australian women ages 20 to 69 showed that 
premenopausal women who had been exposed to oral contraceptives had lumbar spine 
bone density values that were 3.3% higher than those not exposed to oral 
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contraceptives (Pasco et al., 2000).  All studies have not shown an increase in bone 
density as a result of oral contraceptive use.  Prior et al. (2001) looked at oral 
contraceptive use and BMD changes in 524 women ages 25 – 45 years.  They 
observed lower BMD values in premenopausal women who used oral contraceptives 
when compared to premenopausal women who had never used them.  Another study 
examining oral contraceptive use and BMD changes over a 36-month period in women 
aged 18 to 39 years concluded that oral contraceptive did not appear to have any 
impact on bone density during the study period (Reed et al., 2003). 
 One contraceptive of concern is depot medroxyprogesterone acetate (DMPA), 
also known as Depo-Provera, which is injected intramuscularly.  This particular 
contraceptive is of concern due to its ultimate suppression of estrogen production from 
the ovaries (Albertazzi, Bottazzi, and Steel, 2006).  Walsh, Eastell, and Peel (2008) 
found that that DMPA use was associated with a 5% bone density deficit at the hip and 
spine in Caucasian women who starting using it before the age of 20.  This deficit, 
however, was not seen in women who began using Depo-Provera after the age of 34.  
Another study comparing BMD changes in first-time DMPA users to BMD changes in 
nonusers found that BMD of the hip and spine declined after each injection during the 
entire 24 month study period in comparison to a less than 1% decline in nonusers 
(Clark, Sowers, Nichols, and Levy, 2004).  Since the adverse effects of DMPA on bone 
are most pronounced in those who have not attained peak bone mass, it is 
recommended that DMPA not be used in women prior to this attainment (Lewiecki, 
2005). 
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Body Composition/Weight 
 
The link between body composition and BMD is well established, especially in 
older adults.  Coin et al. (2000) determined the relationship between nutritional status 
and bone mass with body composition.  Subjects included 60 women, 30 of whom were 
underweight and 51 men, 30 of whom were underweight.  The low weight women had a 
mean age of 81.3 years and the low weight men had a mean age of 80.8 years.  When 
looking at bone mineral content (BMC) and bone mineral density (BMD) at the femoral 
level, both genders of underweight patients had lower values when compared to normal 
subjects.  Bone turnover were within normal range for the underweight and normal 
weight individuals.  In both men and women for the entire subject population, whole 
body BMD correlated with fat-free soft mass (r = .34 and r = .31, respectively).  BMD 
correlated with appendicular skeletal muscle mass   (r = .35) in men only.  It was 
concluded that, in addition to other factors, malnutrition and osteoporosis is associated 
with low weight in the elderly.   
 Glauber et al. (1995) examined the relationship between bone density and 
weight, body mass index, height, adiposity, regional fat distribution, and frame.  
Subjects were 6,705 non-Black women with an average age of 71.2 years.  Data on 
lifestyle and health-related behaviors were collected as well as weight, height, waist-to-
hip ratio, knee height, and elbow width.  Single- photon absorptiometry was used to 
measure BMD at the distal and proximal radius and the calcaneous during the first visit.  
Dual-energy x-ray absorptiometry was used to measure BMD of the lumbar spine and 
femoral neck.  Bioelectrical impedance analysis was used to measure adiposity.  Weight 
accounted for over 81% of the variability of adiposity on BMD at weight-bearing sites.  
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Thirty-two to 47 % of the effects of adiposity on BMD could be accounted for by weight 
at non-weight bearing sites.  Proximal femoral BMD increased with increases in body 
weight.  Weight, however, did not influence the relationship between BMD and age.  It 
was concluded that due to its loading effects on the skeleton, weight as the major 
anthropomorphic determinant of bone density in late postmenopausal women. 
Ettinger et al. (1997) tested whether or not differences in bone density between 
Black and White males and females could be explained by differences in bone 
metabolism and lifestyle.  Subjects included 109 and 95 Black men and women, 
respectively, and 114 and 84 White men and women recruited from the Kaiser 
Permanente Medical Care Program as a part of the CARDIA study.  DEXA of total body, 
hip, lumbar spine, lean body mass, fat mass, and ratio of trunk to leg fat was performed 
using a densitometer.  Muscle strength of the quadriceps and hamstrings were 
assessed with a dynamometer.  Bone markers and mineral metabolism markers 
creatinine, calcium, phosphorus, bone-specific alkaline phosphatase, intact parathyroid 
hormone, 25D, 1,25 D, and osteocalcin were attained through blood draws.  Growth 
factors and level of sex and adrenal hormones were also measured.  Physical activity, 
diet habits, and medical history including history of tobacco and alcohol use were 
assessed.  Results show that physical activity was higher in Black men than White men 
but was higher in White women in comparison to Black women.  Higher intakes of 
calcium and vitamin D were seen in White women in comparison to Black women.  
Smoking and weight were higher in black subjects in comparison to white subjects.  
Black men had lower abdominal fat than White men whereas Black women had higher 
abdominal fat than White women.  Blacks had significantly higher BMDs at all skeletal 
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sites in comparison to white subjects.  Calcium and vitamin intake were higher in White 
women than in Black women.  No significant differences were seen among men.  Black 
men and women had lower levels of 25D and higher 1,25D levels in comparison to their 
White counterparts.  This study concluded that clinical and biochemical variables 
measured in young adulthood does not explain racial differences in BMD. 
Other studies have focused on children and young adults to establish the 
relationship between BMD and body composition.  Rollins, Imrhan, Czajka-Narins, and 
Nichols (2003) assessed lumbar spine and femoral neck BMD values in 61 Caucasian 
women aged 18 to 30 years.  These women were all healthy and did not have any 
known risk factors that would place them at apparent risk for secondary osteoporosis.  
Participants were divided into a lower weight group (BMI of 16.0 to 19.9) and a normal 
weight group (BMI 23.0 to 25.9).  Results showed that 9 of the 30 women in the lower 
weight group had spinal BMD values in the osteopenic range, according to the WHO 
criteria, in comparison to 2 of the 31 women in the normal weight group who had 
osteopenic spinal BMD values.  Furthermore, none of the normal weight participants 
had femoral neck BMD values within the osteopenia range in comparison to 3 
participants having femoral BMD values within the osteopenia rage. 
Young et al. (2001) sought to determine the degree of association between 
longitudinal changes in bone mineral density and body composition in female twins.  
The subjects included 104 paired female twins and 78 unpaired female twins with their 
subjects being aged 8 to 25 years.  Their subjects were registered with the Australian 
Twin Registry.  Dual energy x-ray absorptiometry (DEXA) was used to measure total 
body fat, total body lean mass, and total body bone mineral content (BMC) as well as 
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bone mineral density (BMD) at the lumbar spine, femoral neck and total hip.  Data on 
menarchial status and height measurements were also taken.  Results showed that 
height increased and changes in lean mass were the greatest 1-year before menarche.  
Changes in fat mass, BMD at the hip and lumbar spine, and total BMC were at their 
largest around the age of menarche.  Association results were reported in annual 
percent changes in lumbar spine and hip areal BMD and total BMC against annual 
changes in lean and fat mass and height rather than with correlation values.  Changes 
in lean mass, fat mass and height were associated with changes in BMD at the lumbar 
spine, femoral neck, total hip, and total body BMC during the linear growth phase.  For 
the post-linear growth phase, femoral BMD changes and total body BMC were 
associated with changes in lean mass and fat mass.  It was concluded that lean mass 
plays a role in building bone during linear growth and that fat mass plays some part in 
maintaining bone density during post-linear growth. 
Reid, Plank, and Evans (1992) evaluated the relationship between bone mineral 
density (BMD) and body composition in men and premenopausal women.  Subjects 
included 68 healthy premenopausal women and 51 healthy men all of which were 
White.  Dual-energy x-ray absorptiometry was used to measure total BMD.  Height and 
weight measurements were also taken for each of the subjects.  Multiple regression 
analysis and correlation coefficients were used to analyze the data.  Results show that 
men were taller and had higher BMDs and lean mass in comparison to women.  Fat 
mass increased with age in women but not in men.  Weight, and lean mass were closely 
associated with BMD in both men and women (r = .56 compared to .69, and .51 
compared to .55 respectively), whereas BMD was related to fat mass in women only (r = 
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.60).  When BMD was expressed as a ratio to height, it was closely associated with fat 
mass in women (r = .57) and just attained significance in men (r = .28).  When multiple 
regression was used to look closer at the relationship between fat and lean mass and 
BMD, lean and fat mass were associated with BMD in women only (R2 = .48).  The 
researchers concluded that although fat mass is related to bone mineral density in 
women, it is not related to bone mineral density in men. 
Wang et al. (2005) attempted to validate the reported findings that amount of 
lean tissue and fat mass affects bone mass and to differentiate between the affect of 
each of these masses on bone mass.  Subjects included 317 African American women, 
154 Asians, 322 Caucasians, and 128 Latinas who were ages 20-25 years and who had 
no known diseases that would affect bone mass.  Height, weight, and reproductive 
history were recorded.  Dual-energy X-ray absorptiometry was used to measure lean 
tissue mass, fat mass, and bone density of the spine, left proximal femur, and whole 
body.  Multiple linear regression, ANOVA, and Bonferroni’s techniques were used to 
analyze the data.  Results show that African Americans had the highest mean weight, 
fat mass and lean tissue whereas Asians had the lowest of all of these.  African 
Americans had the highest bone density and Asians had the lowest at most sites.  Fat 
mass had a significant positive correlation with femoral neck BMD (r = .23).  Lean mass 
and weight had significant positive correlations ranging from 0.34 to 0.76 with femoral 
neck BMD, whole body BMD, whole body BMC, and whole body BMC/height.  Except 
for bone mineral apparent density, lean mass had a significantly greater effect on bone 
density than fat mass for all bone density measures in multiple linear regression.  It is 
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concluded that lean tissue mass has a greater effect on bone density than does fat 
mass in young women. 
 
Physical Activity 
 Osteoporosis is one of the many chronic diseases that can result from a lack of 
physical activity.  Therefore, engaging in physical activity can help prevent osteoporosis.  
Wolff’s Law can explain the mechanism by which exercise improves bone density.  
Wolff’s Law describes bones’ ability to adapt to physical strains that are placed on them 
(K. Khan et al., 2001, ch.3, p. 27).  Since some of the available pharmacological 
therapies are not typically recommended in premenopausal women with low BMD, 
prevention of osteoporosis through diet and exercise is preferable (Lewiecki, 2005).  It is 
important to start these prevention methods early.  Studies have shown that Caucasian 
female adults who participated in sports during their teenage years had a significant 
increase in femoral BMD compared to those who were sedentary as a teenager (Ford, 
Bass, Turner, Mauromustakos, and Graves, 2004; Lloyd et al., 2000).   
 When examining Wolff’s Law, it is noted that the more strain that is put on the 
bones, the stronger they become.  This is the reason why strength training is so 
effective in building BMD.  In a meta-analysis of controlled trials looking at the effect of 
resistance training on BMD in women, it was concluded that resistance training has a 
positive effect on spinal BMD in pre- and postmenopausal women (Kelley, Kelley, and 
Tran, 2001).  This same meta-analysis also found that resistance training had a positive 
effect on BMD in the femur and radius of postmenopausal women (Kelley, Kelley, and 
Tran, 2001). 
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 Although the benefits of physical activity have been well researched, some ethnic 
groups are not taking advantage of these benefits.  When observing physical activity in 
American society, minority women are among the least active subgroups (Geller and 
Derman, 2001).  Furthermore, physical activity is lower in African-American women than 
all other ethnic groups except for Mexican-American women (Adams-Campbell et al., 
2000).  This lack of physical activity among this group places them at increased risk for 
osteoporosis.   
 
Osteoporosis Knowledge 
 It is possible that osteoporosis prevalence is linked to a lack of knowledge 
regarding the disease and its risk factors (Wilson, 2007).  Although one would think that 
knowledge of what is healthy and what is unhealthy will cause a behavior change, 
knowledge alone is often not enough to cause a behavior change (Wallace, 2002).  
Studies have shown that women are typically aware that lack of physical activity and 
low calcium intake are risk factors for osteoporosis (Kasper, Peterson, and Allegrante, 
2001; Ford, Bass, and Keathley, 2007).  However, women are more likely to be 
unaware that factors such as amenorrhea and menopause put them at increased risk 
for osteoporosis (Kasper, Peterson, and Allegrante, 2001).  For this study, osteoporosis 
knowledge will be assessed using the Osteoporosis Knowledge Test (OKT) developed 
by Kim, Horan, Gendler, and Patel (1991).   
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Chapter III 
Methodology 
The primary purpose of this research is to explain the variance in BMD in African-
American and Caucasian college-aged women.  A secondary purpose was to evaluate 
the differences in osteoporosis knowledge among college-aged African-American and 
Caucasian women.  This chapter includes a discussion of the subjects, a description of 
the surveys used, step-by-step data collection procedures, measurements of variables, 
and treatment of the data.  This chapter is divided into the following sections:  (1) 
subjects, (2) subject selection, (3) laboratory procedures, (4) equipment, and (5) 
statistical analysis. 
 
Subjects 
 Participants were 18-30 year-old African American and Caucasian females 
identified in three groups: (a) low weight, (b) normal weight, and (c) high weight.  Power 
analysis indicated that a total of 72 subjects were needed to attain a power of .80 with 
an estimated effect size of .30 at an α-level of .05. 
 
Subject Selection 
Participants were recruited by email, advertising in University classrooms and on 
bulletin boards around the University as well as in doctors’ offices, in local churches, 
and in local newspapers.  Participants were included if they were between the ages of 
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18 and 30, and did not have any conditions that would place them at apparent 
risk (celiac disease, corticosteroid use, and amenorrhea) for low bone mineral density.  
As documented in the initial phone screening, potential participants were questioned 
about apparent osteoporosis risk factors.  The purpose of this questioning was to 
determine if any risk factors would be potential contributors to the current study.  Upon 
initial phone contact with the principal investigator (PI), participants were screened over 
the phone as described in detail on the form “Initial phone contact with potential 
participant” (Appendix A).  The initial phone screening process determined preliminary 
eligibility based on the inclusion/exclusion criteria described.  Secondary eligibility was 
based on the results of the pre-DEXA pregnancy test required prior to an initiation of 
DEXA scan.  Once a participant was deemed preliminarily eligible, the participant was 
scheduled to come in for the initial visit.    
The respective procedures presented no more than minimal risk of harm to the 
involved participants and involved no procedures for which written consent is normally 
required outside of the research context.  In addition, written informed consent was 
obtained at the initial visit prior to any research activities.  This study was approved by 
the University of Mississippi’s Institutional Review Board (IRB Protocol 07-076). 
 
Laboratory Procedures 
All participants were required to meet with the researcher on two occasions.  The 
following procedures were followed with all participants during their initial visit: 
1. Each participant met researcher in the lobby of the Turner Center and then was 
escorted to the Body Composition and Bone Mineral Density Laboratory. 
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2. Each participant was asked to read and sign the informed consent form provided. 
3. Each participant was asked to complete a demographic questionnaire - 
approximately 10 minutes (Appendix D). 
4. Each participant was instructed on how to and asked to complete the 7-day 
Physical Activity Recall instrument – approximately 10 minutes (Appendix C). 
5. Each participant was instructed on how to complete a four-day food log that 
includes 2 weekdays and 2 weekend days – approximately 10 to 15 minutes 
(Appendix E).   
6. Each participant was asked to complete the Osteoporosis Knowledge Test – 
approximately 10 minutes (Appendix B). 
7. The researcher gave a sterile urine specimen container to each participant and 
then gave directions.   
8. The researcher escorted the participant to the restroom and obtained the sample 
from the participant once completed.   
9. The researcher and the participant returned to the Body Composition and Bone 
Mineral Density Laboratory where the researcher analyzed the sample 
(approximately 5 minutes total).  If the pregnancy test was positive, the 
researcher did not perform a DEXA scan on the participant because of this 
positive reading.  This is due to the risks associated with radiation exposure to an 
unborn fetus.  In turn, the participant was ineligible to participate in the study 
based on the documented exclusion criteria.  No potential participant in this study 
had a positive pregnancy test reading. 
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10. After the negative pregnancy test result, each participant was asked to remove 
all metal objects in preparation for the DEXA scan.  
11. Height and weight was obtained using a Detecto scale (Webb City, MO) with the 
participant’s shoes removed (approximately 2 minutes).  
12. Each participant was asked to lie on the DEXA table where non-dominant 
femoral BMD, anterior posterior (AP) spinal BMD, and total body composition 
assessment was performed by a trained DEXA technician using the procedure 
outlined in the Hologic user’s manual (approximately 15 minutes total).  Leg 
dominance is established by coordinative preferences (i.e. kicking a ball) (Sone, 
Imai, Joo, Onodera, and Fukunaga, 2006) in current literature.  The researcher 
asked each participant the following question: If you were to kick a ball, which 
leg/foot would you likely kick with?  
13. Each participant scheduled a day and time, which could not occur sooner than 5 
days after the first meeting, to submit food records, to confirm foods that were 
written in their food record, and to obtain DEXA scan results. 
The following procedures were followed with all participants during their second 
visit: 
1. Each participant met the researcher in the lobby of the Turner Center and then 
was escorted to the Body Composition and Bone Mineral Density Laboratory. 
2. Each participant was asked to confirm foods that were written in their food 
records (15-20 minutes). 
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3. Each participant had the results of their DEXA scans explained and was given a 
copy of the results (5 minutes). 
4. Each participant was given the opportunity to ask questions. 
 
 
Equipment 
DEXA Machine 
The Body Composition and Bone Mineral Density Laboratory at the University of 
Mississippi houses a Hologic Delphi-W (Hologic, Waltham, MA) DEXA machine.  This 
machine is used to measure BMD and body composition.  t-scores and z-scores are 
used to express BMD.  The t-score is based on comparison of an individual’s bone 
density to the bone density of a 25- to 30-year-old, typically the age of peak bone mass, 
of similar gender and race/ethnicity (Winters-Stone, 2005, p. 10).  The individual’s BMD 
is compared with the mean value in a population of similar age, sex, and height when 
using the z-score (Richmond, 2003).   
 Surveys 
 Osteoporosis knowledge was assessed using the Osteoporosis Knowledge Test 
(OKT) developed by Kim, Horan, Gendler, and Patel (1991).  The 24-item, self-
administered, multiple-choice questionnaire has two subscales: OKT calcium and OKT 
exercise whose reliability coefficients for internal consistency are 0.72 and 0.69 
respectively.   
Physical activity was assessed using a 7-day Physical Activity Recall (Dishman 
and Steinhardt, 1988).  Physical activity ranged from 0 to 7.  Participants will receive 1 
point for each day of the week that they exercised a total of at least 30 minutes.  If the 
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total is ≥ 5, then the participant will be considered to have met the physical activity 
requirement. 
All researchers underwent a one-day training session to learn how to instruct 
participants on how to record their food intake.  During their initial visit, each participant 
was given instructions on how to record their food intake over the next 4 days.  
Licensed technicians entered food records into the 4.01 software version of the Nutrition 
Data System for Research (NDS-R).  The NDS-R, which calculates nutrient intake, is a 
dietary analysis program that was developed by the Nutrition Coordinating Center at the 
University of Minnesota in 1998. 
 Anthropometric Data 
The height and weight of all participants were taken using a balance scale 
(Detecto, Webb City, MO) located in the Body Composition and Bone Mineral Density 
Laboratory.  BMI, which is calculated using participant’s weight in kilograms divided by 
height in meters squared, ranged from 16.6 to 36.6. 
 
Statistical Analysis 
 This study included women between the ages of 18 and 30.  Power analysis for 
multiple linear regression (Cohen and Cohen, 1983) indicated that a total of 72 subjects 
were needed to attain a power of .80 with an effect size of .30 at an α-level of .05.  The 
rule of thumb, however, is 10 subjects per independent variable (Darlington, 1990).  The 
following independent variables were included in the analysis to explain the variance in 
spinal BMD and femoral BMD:  age, physical activity, calcium intake, oral contraceptive 
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use, family history of osteoporosis, BMI, and race.  Based on the rule of thumb and if all 
7 predictor variables are used, a total of 70 subjects are recommended.   
 Data were examined for missing data and outliers.  Values for the variance 
inflation factor were examined for each independent variable to determine whether or 
not collinearity existed.  The univariate associations between the dependent variables 
(lumbar spine BMD and femoral BMD) and the previously mentioned independent 
variables were examined.  For spine and femoral skeletal sites, BMD values were 
compared among the two ethnic groups (African-American and Caucasian) by using 
ANOVA.  To determine whether observed ethnic differences in BMD are due to ethnic 
variation in factors that affect BMD were compared again with lumbar spine BMD and 
femur BMD values using multivariate linear regression.  Data were analyzed using 
SPSS version 17.0.    
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Chapter IV 
Results 
The primary purpose of this research project was to explain the variance in BMD 
in African-American and Caucasian college-aged women.  A secondary purpose was to 
evaluate the differences in osteoporosis knowledge among college-aged African-
American and Caucasian women.  This chapter is presented in the following sections: 
(1) description of the sample, (2) survey responses, (3) nutrition, (4) Osteoporosis 
Knowledge Test responses, (5) univariate results, (6) multivariable results, and (7) 
summary of results and formal hypotheses. 
 
Description of the Sample 
 A total of 107 women ages 18 – 30 years old, which live in a southern state, were 
enrolled in this study.  Six participants were not used in the statistical analyses due to: 
dual hip surgeries (n = 2), multiple episodes of amenorrhea (n = 1), bone marrow 
transplant (n = 1), and non-completion of the study due to time constraints (n = 2).  
Therefore, 101 participants were included in the analyses.  African-American women 
comprised 49.5% of the sample.  Caucasian women comprised 50.5% of the sample.  
Table 4-1 summarizes the demographics of the study population.  African-American and 
Caucasian women had similar demographics in terms of their mean age, 
anthropometric measures, and BMD scores.  The mean age of African-American 
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women was 21.00 years (±1.75), whereas the mean age of Caucasian women was 
approximately 21.55 years (±2.62).  There were, however, significant differences 
between African-American and Caucasian participants regarding total hours of exercise 
and calcium intake. 
Table 4 – 1 
 
Mean and Standard Deviation (SD) of Demographics/Characteristics Overall and by Race 
 
 
African 
American 
 
 Caucasian 
 
 Overall 
 
 
Demographics (n = 50) SD (n = 51) SD (N = 101) SD 
Age (Years) 21.00  ±1.75 21.55 ±2.62  21.30 ±2.24 
 
Body Mass Index 23.80  ±4.87 22.96 ±3.81  23.40 ±4.37 
 
Spinal BMD (t-score) -0.57  ±1.04 -0.40 ±1.01
 
-0.49 ±1.02 
 
Femoral BMD (t-score) 0.30  ±0.89 0.52 ±1.05
 
0.41 ±0.98  
 
Hours of Exercise 3.36  ±4.39 7.69 ±7.53
 
5.54 ±6.52*
 
Grams of Calcium 0.75  ±0.29 0.98 ±0.44
 
0.87 ±0.39*
 
 
Length of Time on Oral 
Contraceptives (months) 
19.04 
                                                                                                                              
±25.02 29.75 ±30.35
 
24.50 ±28.22 
 
*p < 0.05 
 
For the purposes of this study, participants were stratified into three weight 
categories:  1) low weight if BMI ≤ 20.4 kg/m2, 2) normal weight if 20.5 ≤ BMI kg/m2 ≤ 
24.4 kg/m2 and 3) high weight if BMI ≥ 24.5 kg/m2.  Participants were stratified in this 
way closely emulate the BMI cutoffs set by the World Health Organization [WHO].  The 
WHO’s cutoffs are as follows:  1) underweight if BMI < 18.5 kg/m2, 2) normal weight if 
18.5 kg/m2 < BMI ≤ 24.9 kg/m2, and 3) overweight if BMI ≥ 25 kg/m2 (World Health 
Organization, 2000).  The number of participants by race for each of the weight 
categories is provided in Table 4-2.  Among African Americans, 42% were of a high-
weight status (BMI ≥ 24.5 kg/m2) whereas 26% were of low-weight status (BMI ≤ 20.4 
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kg/m2).  There was a 1:1 ratio of Caucasian women of a low-weight status (BMI ≤ 20.4 
kg/m2) compared to Caucasian women of a high-weight status (BMI ≥ 24.5 kg/m2). 
Table 4 – 2    
 
Mean, Minimum and Maximum Values for Body Mass Index (BMI) Categories with SD* Overall and by 
Race 
 
Weight Categories N       Min. Max. Mean SD 
Low: BMI ≤ 20.4 kg/m2 31 94.0 149.5 113.8 10.9 
     African-American 13 94.0 125.0 109.4 10.5 
     Caucasian 
 
18 105.0 149.5 116.9 10.3 
Normal: 20.5 kg/m2 ≤ BMI ≤ 24.4 kg/m2 31 109.0 155.0 133.7 11.8 
     African-American 16 109.0 150.0 130.5 11.9 
     Caucasian 
 
15 118.0 155.0 137.2 11.1 
High: BMI ≥ 24.5 kg/m2 39 133.0 222.0 164.7 20.2 
     African-American 21 144.0 222.0 169.0 22.0 
     Caucasian 18 133.0 201.0 159.6 17.2 
*Standard Deviation 
 
 The mean spinal BMD for each race and weight category is provided in Table 4 – 
3.  The mean spinal BMD was higher in individuals belonging to the high-weight 
category (BMI ≥ 24.5 kg/m2) in comparison to the low-weight category (BMI ≤ 20.4 
kg/m2).  It is noteworthy that Caucasians in the low-weight group (BMI ≤ 20.4 kg/m2) had 
a higher maximal spinal BMD than African Americans in that same weight category.  
Significance testing of these findings will be discussed in detail later in this chapter. 
 The mean femoral BMD for each race and weight category is provided in Table 4 
– 4.  Similar to the mean spinal BMD, the mean femoral BMD was higher in individuals 
belonging to the high-weight category (BMI ≥ 24.5 kg/m2) in comparison to the low-
weight category (BMI ≤ 20.4 kg/m2).  Also, similar to that seen with mean spinal BMD, 
Caucasians in the low-weight group and in the normal weight group (20.5 ≤ BMI kg/m2 ≤ 
24.4 kg/m2) had higher maximal femoral BMDs than African Americans in each 
comparison weight category (2.30 versus 0.90, and 2.40 versus 2.30, respectively). 
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Table 4 – 3  
 
Mean, Minimum and Maximum Spinal BMD Values with SD* for Race and Weight Categories 
 
Weight Categories N Min. Max. Mean SD 
Low: BMI ≤ 20.4 kg/m2 31 -2.70 1.60 -0.82 0.98 
     African-American 13 -2.60 0.70 -0.98 0.98 
     Caucasian 
 
18 -2.70 1.60 -0.71 1.00 
Normal: 20.5 kg/m2 ≤ BMI ≤ 24.4 kg/m2 31 -2.10 1.20 -0.72 0.93 
     African-American 16 -2.10 1.20 -0.90 0.92 
     Caucasian 
 
15 -2.10 0.90 0.61 0.86 
High: BMI ≥ 24.5 kg/m2 39 -1.80 2.40 -0.03 0.97 
     African-American 21 -1.70 2.40 -0.07 0.98 
     Caucasian 18 -1.80 1.80 0.88 1.10 
*Standard Deviation 
 
Table 4 – 4   
Mean, Minimum and Maximum Femoral BMD Values with SD* by Race and Weight Categories 
 
Weight Categories N Min. Max. Mean SD 
Low: BMI ≤ 20.4 kg/m2 31 -1.70 2.30 0.00 0.94 
     African-American 13 -1.50 0.90 -0.12 0.80 
     Caucasian 
 
18 -1.70 2.30 0.08 1.04 
Normal: 20.5 kg/m2 ≤ BMI ≤ 24.4 kg/m2 31 -1.20 2.40 0.47 0.86 
     African-American 16 -1.20 2.30 0.34 0.86 
     Caucasian 
 
15 -0.70 2.40 0.61 0.86 
High: BMI ≥ 24.5 kg/m2 39 -1.00 2.50 0.67 1.01 
     African-American 21 -0.90 2.50 0.52 0.92 
     Caucasian 18 -1.00 2.10 0.88 1.10 
*Standard Deviation 
 Spinal BMD categories for each weight category for entire sample are 
summarized in Table 4 - 5.  Individuals were classified as having low spinal BMD if their 
t-score was ≤ -1.0.  They were classified as having normal spinal BMD if their t-score 
was > -1.0.  Among the 31 participants who were of a low-weight status (BMI ≤ 20.4 
kg/m2), nearly 55% also had low spinal BMD.  It is also worth mentioning that 17.9% of 
those of a high-weight status (BMI ≥ 24.5 kg/m2) also had low spinal BMD.   
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Table 4 – 5 
 
Body Mass Index Categories by Spinal Bone Mineral Density Categories of All Participants (%) 
 
 
 
Weight Categories 
          Spinal BMD Categories  
    Low BMD 
   n (%) 
Normal BMD 
n (%) 
Total  
 
Low weight: BMI ≤ 20.4 kg/m2  17 (43.6%) 14 (22.6%)  31 
Normal weight: 20.5 kg/m2 ≤ BMI ≤ 24.4 kg/m2  15 (38.5%) 16 (25.8%)  31  
High weight: BMI ≥ 24.5 kg/m2  7(17.9%) 32 (51.6%)  39  
Total  39 62  101 
 
Femoral BMD and weight categories for the entire sample are summarized in 
Table 4 - 6.  Individuals were classified as having low femoral BMD if their t-score was ≤ 
-1.0 and as having normal femoral BMD if their t-score was > -1.0.  The study sample 
had a higher prevalence of low spinal BMD than low femoral BMD (38.6% versus 7.9%, 
respectively).  Individuals who were of a low weight status (BMI ≤ 20.4 kg/m2), were 
more than four times as likely to have low femoral BMD in comparison to those who 
were of a normal or high weight status (20.5 ≤ BMI kg/m2 ≤ 24.4 kg/m2 and BMI ≥ 24.5 
kg/m2).  Refer to Figure 1 and Figure 2 in Appendix F for a graphical representation of 
how participants with low spinal and femoral BMD compare with participants with 
normal spinal and femoral BMD according to demographics/characteristics. 
Caucasians’ spinal BMD status and weight category are summarized in Table 4 – 
7.  It is noteworthy that 35.3% of Caucasian participants had low spinal BMD (t-score < -
1.0).  Half of the Caucasians with low spinal BMD were classified as having a low 
weight (BMI ≤ 20.4 kg/m2) whereas 22.2% were classified as having a high weight (BMI 
≥ 24.5 kg/m2).  The remaining 27.8% of those with low spinal BMD were classified as 
having a normal weight (20.5 ≤ BMI kg/m2 ≤ 24.4 kg/m2).   
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Table 4 – 6 
 
Body Mass Index Categories by Femoral Bone Mineral Density Categories of All Participants (%) 
 
 
 
Weight Categories 
         Femoral BMD Categories 
 
  Low BMD 
n (%) 
Normal BMD 
n (%)  
 Total 
  N 
Low weight: BMI ≤ 20.4 kg/m2  6 (75.0%) 25 (26.9%)  31  
Normal weight: 20.5 kg/m2 ≤ BMI ≤ 24.4 kg/m2  1 (12.5%) 30 (32.3%)  31 
High weight: BMI ≥ 24.5 kg/m2  1 (12.5%) 38 (40.9%)  39  
Total  8 93  101 
 
Table 4 – 7   
 
Body Mass Index Categories by Spinal Bone Mineral Density Categories of Caucasians (%) 
 
 
 
Weight Categories 
           Spinal BMD Categories 
 Total  
    
      Low BMD 
  n (%) 
Normal BMD 
n (%) 
Low weight: BMI ≤ 20.4 kg/m2  9 (50.0%) 9 (27.3 %)  18 
Normal weight: 20.5 kg/m2 ≤ BMI ≤ 24.4 kg/m2  5 (27.8%) 10 (30.3%)  15 
High weight: BMI ≥ 24.5 kg/m2  4 (22.2%) 14 (42.4%)  18 
Total (N)  18 33   51 
 
 Caucasians’ femoral BMD status and weight category are summarized in Table 4 
– 8.  Among the Caucasian participants, 7.8% had low femoral BMD values (t-score < -
1.0) with 75% of those with low femoral BMD being found in the low weight group (BMI 
≤ 20.4 kg/m2).  The remaining 25% were in the high weight group (BMI ≥ 24.5 kg/m2). 
African Americans’ spinal BMD status and weight category are summarized in 
Table 4 – 9.  It is noteworthy that 42% of African-American participants had low spinal 
BMD (t-score < -1.0).  Among those with low spinal BMD, 38% were classified as low 
weight (BMI ≤ 20.4 kg/m2) whereas 14.3% of a high weight (BMI ≥ 24.5 kg/m2).  The 
remaining 47% with low spinal BMD were classified as having a normal weight (20.5 ≤ 
BMI kg/m2 ≤ 24.4 kg/m2).  The presence of low spinal BMD (t-score < -1.0) was more 
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prevalent in African-American participants, who had 21 individuals with low spinal BMD, 
in comparison to Caucasian participants, who had 18 individuals with low spinal BMD 
(42% versus 35.3%, respectively). 
 
Table 4 – 8   
 
Body Mass Index Categories by Femoral Bone Mineral Density Categories of Caucasians (%) 
 
 
 
Weight Categories 
      Femoral BMD Categories 
   Total  
    
  Low BMD 
    n (%) 
Normal BMD 
n (%) 
Low weight: BMI ≤ 20.4 kg/m2  3 (75.0%) 15 (31.9%)  18 
Normal weight: 20.5 kg/m2 ≤ BMI ≤ 24.4 kg/m2  0 (0.00%) 15 (31.9%)  15 
High weight: BMI ≥ 24.5 kg/m2  1 (25.0%) 17 (36.2%)  18 
Total (N)  4 47   51 
 
 
African Americans’ femoral BMD status and on weight category, is summarized 
in Table 4 – 10.  Among the African-American participants, 8% had low femoral BMD (t-
score < -1.0) values with 75% of those with low femoral BMD being found in the low 
weight group (BMI ≤ 20.4 kg/m2).  The remaining 25% were in the normal weight group 
(20.5 ≤ BMI kg/m2 ≤ 24.4 kg/m2).  Caucasian and African-American participants were 
almost equally affected by low femoral BMD (t-score < -1.0) with 7.8% of Caucasians 
and 8% of African Americans having low BMD.  Refer to Figure 3 and Figure 4 in 
Appendix F for a graphical representation of how African-Americans with low spinal and 
femoral BMD compare with Caucasian participants with low spinal and femoral BMD 
according to demographics/characteristics. 
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Table 4 – 9 
 
Body Mass Index Categories by Spinal Bone Mineral Density Categories of African-Americans (%) 
 
 
 
Weight Categories 
   Spinal BMD Categories 
  Total  
   
  Low BMD  
  n (%) 
Normal 
n (%) 
Low weight: BMI ≤ 20.4 kg/m2  8 (38.1%) 5 (17.2%)  13 
Normal weight: 20.5 kg/m2 ≤ BMI ≤ 24.4 kg/m2  10 (47.6%) 6 (20.7%)  16 
High weight: BMI ≥ 24.5 kg/m2  3 (14.3%) 18 (62.1%)  21 
Total (N)  21 29  50 
 
 
Table 4 – 10   
 
Body Mass Index Categories by Femoral Bone Mineral Density Categories of African-Americans (%) 
 
 
 
Weight Categories 
   Femoral BMD Categories 
 
   Total  
    
   Low BMD 
    n (%) 
Normal 
n (%) 
Low weight: BMI ≤ 20.4 kg/m2  3 (75.0%) 10 (21.7%)  13 
Normal weight: 20.5 kg/m2 ≤ BMI ≤ 24.4 kg/m2  1 (25.0%) 15 (32.6%)  16 
High weight: BMI ≥ 24.5 kg/m2  0 (0.0%) 21 (45.7%)  21 
Total (N)  4 46  50 
 
 
Survey Responses 
The following questions are summarized in Table 4 – 11 according to race.  Family 
history of osteoporosis was more likely to occur in Caucasians in comparison to African 
Americans (31.4% versus 2%, respectively).  Caucasians were also more likely than 
African Americans to have a family history of fracture (17.6% versus 6%, respectively).  
African Americans were less likely to have been breastfed as a child in comparison to 
Caucasians (22% versus 68.6%, respectively).  African Americans were also less likely 
to be a current smoker in comparison to Caucasians (2% versus 9.8%, respectively).  
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Additionally, African- American participants were more likely to have used Depo-
Provera in comparison to Caucasians (18% versus 2%, respectively).  Lastly, 
Caucasians were more likely to meet exercise requirements in comparison to African 
Americans (29.4% versus 14%, respectively). 
 
Table 4 – 11 
 
Percentages of Participants’ Correct Responses to Survey Items According to Race 
 
 
Items 
African Americans 
n = 50 
Caucasians 
n = 51 
Family history of osteoporosis 2.0%  31.4%  
No family history of osteoporosis 80.0%  51.0%  
Unaware of family history of osteoporosis 
 
18.0%  17.6%  
Has family history of fracture 6.0% 
 
17.6%  
No family history of fracture 82.0% 
 
72.5%  
Does not know family history of fracture 
 
12.0% 
 
9.8%  
Breastfed as child 22.0% 
 
68.6%  
Not breastfed as child 62.0% 
 
25.5%  
Unaware of being breastfed as child 
 
16.0% 
 
5.9%  
No milk consumption as a child 6.0% 
 
9.8%  
About 1 serving of milk  per day as a child 18.0% 
 
29.4%  
About 2 servings of milk per day as a child 44.0% 
 
27.5%  
About 3 servings of milk per day as a child 22.0% 
 
27.5%  
About 4 or more servings of milk per day as a child 
 
10.0% 
 
5.9%  
Smokes 2.0% 
 
9.8%  
Does not smoke 
 
98.0% 
 
90.2%  
Oral contraceptive use 62.0% 
 
76.5%  
Depo-Provera use 
 
18.0% 
 
2.0%  
High school sports participation *64.6% 
 
90.2%  
 
Met exercise requirements 
 
14.0% 
 
 
29.4% 
 
*n=48 
Family history of osteoporosis was determined by self-reported information 
obtained from two questions:  “Was your biological mother or grandmother ever told by 
a doctor that they had osteoporosis, sometimes called thin or brittle bones?” and “Did 
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your biological mother or grandmother ever fracture her hip?”  Participants chose from 
the options of “Yes,” “No,” or “I don’t know.”  It was reported by 16.8% of the participants 
that their biological mother or grandmother was diagnosed with osteoporosis; whereas 
65.3% reported that their biological mother or grandmother had not been diagnosed 
with osteoporosis; and 17.8% reported not knowing whether or not their biological 
mother or grandmother had been diagnosed with osteoporosis.  Among the 16.8% who 
reported that their biological mother or grandmother had been diagnosed with 
osteoporosis, three participants reported that their biological mother or grandmother had 
suffered a hip fracture.    
Absence or presence of consumption of breast milk as a child was determined 
through the question:  “When you were a baby, were you breastfed?”  The response 
options were “Yes,” “No,” and “I don’t know.”  It was reported by 45.5% of the 
participants that they were breastfed as a child whereas 43.6% reported not being 
breastfed as a child; and 10.9% reported not knowing whether or not they were 
breastfed as a child.  Data were obtained regarding childhood milk consumption through 
the question, “During your childhood, approximately how many servings of milk did you 
drink each day?”  The answer choices were “None,” “1 serving,” “2 servings,” “3 
servings,” and “4 or more servings.”  It was reported by 7.9% that they consumed no 
milk during their childhood; 23.8% reported having 1 serving of milk per day during 
childhood; 35.6% reported having 2 servings of milk per day; 24.8% reported 3 servings 
of milk per day; and 7.9% reported having 4 or more servings per day.   
Current smoking habits were identified by the question, “Do you smoke?” and the 
answer choices were “Yes” and “No.”  Six individuals reported being current smokers 
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whereas 94.1% reported being non-smokers.  This means that only six participants 
reported being a current smoker.  Of the six who reported being a current smoker, one 
was African-American and the remaining five were Caucasian. 
Information regarding contraceptive use was obtained by the question, “Have you 
ever taken birth control pills for any reason?”  The answer choices were “Yes” and “No.”  
Oral contraceptive use was reported by 69.3% of the participants whereas 30.7% 
reported no oral contraceptive.  Length of time on oral contraceptives was obtained from 
each participant by asking, “How long all together have you taken birth control pills?”  
Information regarding Depo-Provera use was obtained through the question, “Have you 
ever had the Depo-Provera shot?” and the answer choices were “Yes” and “No.”  Depo-
Provera use was reported by 9.9% of the participants.   
High school sports participation was assessed by the question, “Did you 
participate in sports in high school?” with the answer choices being “Yes” and “No.”  
Among the 99 participants who responded to the question, 22.2% reported not 
participating in high school sports while 77.8% reported participating in high school 
sports. 
Physical activity was assessed using a 7-day Physical Activity Recall (Dishman 
and Steinhardt, 1988).  This instrument records moderate and vigorous physical activity.  
For the purpose of this study, the time spent engaging in moderate and vigorous 
physical activities were combined.  Participants were classified as meeting exercise 
requirements if they engaged in at least 30 minutes of exercise, regardless of intensity, 
on not less than five days of the week.  This is a primary guideline set forth by the 
American College of Sports Medicine and the American Heart Association for adults 
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aged 18 to 65 years (Haskell et al., 2007).  Only 21.8% of the participants met these 
requirements.  Caucasian participants were more likely to engage in the recommended 
amount of exercise than African-American participants (29.4% versus 14%, 
respectively).  There was also a significant difference (p = 0.001) between Caucasian 
and African-American participants regarding total hours of exercise with Caucasians 
spending more time engaged in physical activity than African-Americans.  Caucasians 
reported spending an average of 7.69 hours per week engaged in physical activity in 
comparison to an average of 3.36 hours per week reported by African-Americans. 
  
 
Nutrition  
Nutrient intake was determined from each participant’s 4-day dietary record.  
Each participant’s record was entered into NDS-R.  NDS-R is a dietary analysis 
program developed by the Nutrition Coordinating Center at the University of Minnesota 
in 1998.  Three individuals who did not provide a complete 4-day recall were not 
included in the analyses involving nutrient data.  Table 4 – 12 shows the percentage of 
participants meeting the RDA for calcium, vitamin D, iron, zinc, and magnesium.  The 
main nutrient of interest for the present study is calcium.  The RDA of calcium for 
women up until the age of 18 years is 1300 mg/day.  After the age of 18 years, the RDA 
is 1000 mg/day (NOF, 2008).  There was a significant difference (p = 0.002) in calcium 
intake between African-American and Caucasian participants.  Caucasian women were 
more likely than African-American women to meet the RDA for calcium (37.3% versus 
16% respectively).  Caucasians were also more likely than African Americans to meet 
the RDA for magnesium (27.5% versus 6% respectively).   
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Table 4 – 12 
 
Percentage of African-Americans, Caucasians, and Total Sample Meeting Recommended Dietary 
Allowance for Calcium, Vitamin D, Iron, Zinc, and Magnesium 
  
 
 
 
 
 African  
American 
 
Caucasian 
 
Total 
Nutrients  (n = 50) (n = 51) (N = 101) 
Calcium 16.0%  37.3% 26.7% 
Vitamin D 46.0%  56.9% 51.5% 
Iron  32.0%  39.2% 35.6% 
Zinc 72.0%  66.7% 69.3% 
Magnesium 6.0%  27.5% 16.8% 
 
 
Osteoporosis Knowledge Test Responses 
 Osteoporosis knowledge was assessed using the Osteoporosis Knowledge Test 
(OKT) developed by Kim, Horan, Gendler, and Patel (1991).  The items included in the 
OKT and the percentage of correct answers for African Americans and Caucasians are 
reported in Table 4 – 13.  Refer to Appendix C for complete instrument.  It is noteworthy 
that more than 70% of Caucasian participants and more than 60% of African-American 
participants did not realize that being a White woman with fair skin increases 
osteoporosis risk.  It is also noteworthy that 90% of African Americans and 87% of 
Caucasians surveyed did not know the recommended milligrams of calcium intake for 
adults.  Seventy percent of African Americans and 69% of Caucasians did not know that 
bone size affects osteoporosis risk.  Having ovaries surgically removed was not  
correctly identified as a risk factor for osteoporosis by 82% of the African- American 
participants and 63% of Caucasians.  More than 50% of African- American and 
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Table 4 – 13  
Percentage of Correct Responses on Osteoporosis Knowledge Test for Each Race and Overall
 
Caucasian participants (56% & 67%, respectively) did not know that brisk walking and 
bicycling (52% & 57%, respectively) were better modes of exercise for preventing 
osteoporosis than kitchen chores, yoga, swimming, and house cleaning.  Lastly, 78% of 
African Americans and 75% of Caucasians did not know that canned sardines were a 
better source of calcium than watermelon and corn.  Refer to Figure 5 in Appendix F for 
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a graphical representation of where African-American and Caucasian participants 
differed in correct responses on the Osteoporosis Knowledge Test. 
 
Univariate Findings 
 ANOVAs, t-tests, and correlations were performed to examine the relationship of 
each outcome variable, femoral and spinal BMD, with all of the predictor variables.  The 
alpha level was set at 0.05 a priori.   
 Independent t-tests were conducted to test mean difference in BMD for each 
predictor.  The alpha level was set at 0.05 a priori.  The results of these tests for spinal 
BMD are shown in Table 4 – 14.  Based on the results from the t-test as seen in Table 4 
– 14, there was no statistically significant difference between mean spinal BMD for 
African Americans and Caucasians (p = 0.42).  There were no significant differences in 
mean spinal BMD (p > 0.05) based on any of the remaining predictors listed in Table 4 – 
14 (oral contraceptive use, calcium intake, present physical activity, high school sports 
participation, osteoporosis knowledge and age).  
The results of the t-tests for femoral BMD are shown in Table 4 – 15.  Based on 
the results from Table 4 – 15, there was no statistically significant difference between 
mean femoral BMD for African Americans compared to that of Caucasians.  There were 
no significant differences in mean femoral BMD (p > 0.05) based on any of the 
remaining predictors listed in Table 4 – 15. 
Mean difference in spinal BMD between African-Americans and Caucasians 
were computed and tested for each BMI category using t-tests as indicated in Table 4 – 
16.  Based on the 95% confidence intervals (include zero) and the p-values (p>0.05) 
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there was not a statistically significant difference (p = 0.47) in African Americans’ mean 
spinal BMD and Caucasians’ spinal BMD for those in the low BMI category (BMI ≤ 20.4 
kg/m2).  There also was no statistically significant differences (p = 0.28) in mean spinal 
BMD between African Americans and Caucasians in the normal BMI category.  
Furthermore, there was not a statistically significant difference (p = 0.82) in African 
Americans’ mean spinal BMD and Caucasians’ spinal BMD for those in the high BMI 
category (BMI ≥ 24.5 kg/m2). 
Table 4 – 14 
Results of t-tests for Spinal Bone Mineral Density (BMD) Differences for Race, Oral Contraceptive Use, 
RDA of Calcium, Physical Activity High School Sports Participation, Osteoporosis Knowledge, and Age 
for Entire Sample 
 
 
 
Categorical Variables 
 
 
n 
 
Mean 
BMD 
 
Mean 
Difference 
 
95% Confidence 
Interval 
 
 
t-test 
Race 
  African American 
  Caucasian 
 
50 
51 
 
-0.57 
-0.40 
0.16 -0.24, 0.57 
 
 
0.81, p = 0.42 
      
Oral Contraceptive Use 
  Yes 
  No 
 
70 
31 
 
-0.57 
-0.29 
-0.28 -0.71, 0.16 
 
 
 
-1.26, p = 0.21 
RDA of Calcium 
  Meets 
  Does not meet 
 
27 
74 
 
-0.55 
-0.46 
0.09 -0.37, 0.54 0.37, p = 0.71 
Physical Activity 
  Meets requirement 
  Does not meet  
 
22 
79 
 
-0.42 
-0.50 
-0.09 -0.58, 0.41 -0.35, p = 0.73 
 
High School Sports 
Participation 
  Yes 
  No 
 
 
 
77 
22 
 
 
 
-0.47 
-0.61 
 
 
-0.14 
 
 
-0.64, 0.35 
 
 
-0.58, p = 0.56 
 
Osteoporosis Knowledge  
  Less than 70% Correct 
  ≥70% Correct 
 
 
77 
24 
 
 
-0.46 
-0.57 
 
0.11 
 
-0.36, 0.59 
 
0.47, p = 0.64 
 
Age 
  18 to 24 
  25 to 30 
 
 
93 
  8 
 
 
-0.46 
-0.80 
 
0.34 
 
-0.41, 1.09 
 
0.91, p = 0.37 
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Table 4 – 15 
 
Results of t-tests for Femoral Bone Mineral Density (BMD) Differences According to Race, Oral 
Contraceptive Use, RDA of Calcium, Physical Activity High School Sports Participation, Osteoporosis 
Knowledge, and Age for Entire Sample 
 
 
Mean difference in femoral BMD between races was computed for each BMI 
category using t-tests.  Results are shown in Table 4 – 17.  As indicated in Table 4 – 17, 
there was not a statistically significant difference (p = 0.57) in African Americans’ mean 
spinal BMD and Caucasians’ spinal BMD for those in the low BMI category (BMI ≤ 20.4 
kg/m2).  There also was no significant difference (p = 0.39) in mean spinal BMD 
between African Americans and Caucasians in the normal BMI category.  Furthermore, 
there was not a statistically significant difference (p = 0.28) in African Americans’ mean 
 
 
Categorical Variables 
 
 
n 
  
Mean 
BMD 
 
Mean 
Difference 
95% 
Confidence 
Interval 
  
 
t-test 
Race 
  African American 
  Caucasian 
 
50 
51 
  
0.30 
0.52 
0.22 -0.17, 0.60 
 
 
 
1.13, p=0.26 
 
Oral Contraceptive Use 
  Yes 
  No 
 
 
70 
31 
  
 
0.31 
0.64 
 
-0.33 
 
-0.75, 0.08 
 
  
-1.56, p = 0.12 
 
RDA of Calcium 
  Meets 
  Does not meet 
 
 
27 
74 
  
 
0.52 
0.37 
 
 
-0.15 
 
-0.59, 0.28 
  
-0.70, p = 0.48 
Physical Activity 
  Meets requirement 
  Does not meet  
 
22 
79 
  
0.45 
0.40 
-0.05 
 
-0.52, 0.42  -0.22, p= 0.83 
 
High School Sports Participation 
  Yes 
  No 
 
 
 
77 
22 
  
 
 
0.52 
0.07 
 
 
-0.45 
 
 
-0.91, 0.02 
  
 
-1.90, p = 0.06 
 
Osteoporosis Knowledge  
  Less than 70% Correct 
  ≥70% Correct 
 
 
77 
24 
  
 
0.40 
0.45 
 
-0.05 
 
-0.50, 0.41 
  
-0.21, p = 0.83 
 
Age 
  18 to 24 
  25 to 30 
 
 
93 
8 
  
 
0.43 
0.11 
 
0.32 
 
-0.39, 1.04 
  
0.89, p = 0.37 
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spinal BMD and Caucasians’ spinal BMD for those in the high BMI category (BMI ≥ 24.5 
kg/m2).  
Table 4 – 16 
 
Mean Difference in Spinal Bone Mineral Density (BMD) Between African Americans and Caucasians for 
Low, Normal, and High Body Mass Index Categories 
 
 
 
BMI Categories 
 
 
Race 
 
 
n 
 
Mean 
BMD 
 
Mean 
Difference 
95% 
Confidence 
Interval 
 
 
p 
Low:  
(BMI ≤ 20.4 kg/m2) 
   
African 
American 
Caucasian 
 
 
13 
18 
 
 
-0.98 
-0.71 
0.27 -0.47, 1.00 
 
 
p = 0.47 
 
Normal : 
(20.5 kg/m2 ≥ BMI ≥ 
24.45 kg/m2) 
 
 
 
African 
American 
Caucasian 
 
 
 
 
16 
15 
 
 
 
-0.89 
-0.53 
 
0.33 
 
-0.32, 1.05 
 
 
 
 
p = 0.28 
High: (BMI ≥ 24.5 
kg/m2) 
 
African 
American 
Caucasian 
 
 
21 
18 
 
 
-0.07 
0.01 
0.07 -0.57, 0.71 p = 0.82 
 
 
Table 4 – 17 
Mean Difference in Femoral Bone Mineral Density (BMD) Between African Americans and Caucasians for 
Low, Normal, and High Body Mass Index Categories 
 
 
 
BMI Categories 
 
 
Race 
 
 
n 
  
Mean 
BMD 
 
Mean 
Difference 
95% 
Confidence 
Interval 
 
 
p 
Low:  
(BMI ≤ 20.4 kg/m2) 
 
African- 
American 
Caucasian 
 
 
13 
18 
  
 
-0.12 
0.08 
0.20 -0.51, 0.91  p = 0.57 
 
Normal : 
(20.5 kg/m2 ≥ BMI 
≥ 24.45 kg/m2) 
 
 
 
African- 
American 
Caucasian 
 
 
 
16 
15 
  
 
 
0.34 
0.61 
 
0.27 
 
-0.36, 0.90 
 
 p = 0.39 
 
 
High: (BMI ≥ 24.5 
kg/m2) 
 
 
 
African 
American 
Caucasian 
 
 
 
 
21 
18 
  
 
 
 
0.52 
0.88 
 
 
0.35 
 
 
-0.30, 1.01 
 
 
p = 0.28 
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 ANOVAs were performed to test whether the means of femoral BMD and spinal 
BMD differed according to race and BMI category.  The results are shown in Tables 4 – 
18 and 4 – 19.  The results showed that both spinal and femoral BMD means were 
significantly different for BMI categories (p = 0.001 and p = 0.01, respectively).  Spinal 
and femoral BMD means were not significantly different for race category or the 
interaction between race and BMI category (p > 0.05).    
Table 4 – 18 
 
ANOVA Results for Comparison of Spinal Bone Mineral Density According to Race and Body Mass Index 
(BMI) Category 
 
            F p 
RACE 1.45  0.23 
BMI CATEGORY 7.14  0.001 
RACE * BMI CATEGORY 0.21  0.81 
 
 
 
Table 4 – 19 
 
ANOVA Results for Comparison of Femoral Bone Mineral Density According to Race and Body Mass 
Index (BMI) Category 
 
                                                                                                        F                         p 
RACE 2.07 0.15 
BMI CATEGORY 4.96 0.01 
RACE * BMI CATEGORY 0.06 0.94 
 
 Since, femoral and spinal BMD means were significantly different based on BMI 
category, Bonferroni post-hoc tests were conducted to examine which BMI categories 
had significantly different spinal and femoral BMD means.  Bonferroni post-hoc results 
for femoral BMD are shown in Table 4 – 20.  According to the results, the mean femoral 
BMD of participants with a low BMI category was significantly different from the femoral 
BMD of participants with a high BMI (p = 0.01).   
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Table 4 – 20 
 
Bonferroni Comparison of Body Mass Index Categories (BMI) for Femoral Bone Mineral Density 
 
 
 
Comparisons 
 
Mean BMD 
Difference 
 
Std. 
Error 
 
95% Confidence 
Interval 
 
 
p 
Low BMI vs. Normal BMI -0.47 0.24 -1.05, 0.12 0.16 
Low BMI vs. High BMI -0.69 0.23 -1.24, -0.13 0.01 
Normal BMI vs. High BMI -0.22 0.23 -0.34, 0.77 1.00 
 
 Bonferroni post-hoc results for spinal BMD are shown in Table 4 – 21.  These 
results for spinal BMD showed that the mean spinal BMD of participants with a low BMI 
was significantly different from the mean spinal BMD of participants with a high BMI (p = 
0.001).  It also showed that the mean spinal BMD of individuals with normal BMIs were 
significantly different from the mean spinal BMD of individuals with high BMIs (p = 0.01).   
Table 4 – 21 
 
Bonferroni Comparison of Body Mass Index Categories (BMI) for Spinal Bone Mineral Density 
 
 
Comparisons 
Mean BMD 
Difference 
Std. 
Error 
95% Confidence 
Interval 
 
p 
Low BMI vs. Normal BMI -0.11 0.25 -0.71, 0.50  1.00 
Low BMI vs. High BMI -0.79 0.23 -1.36, -0.22  0.003 
Normal BMI vs. High BMI 0.68 0.23 0.13, 1.25  0.01 
 
 ANOVAs were performed to test whether the femoral BMD and spinal BMD 
means differ according to family history of osteoporosis categories.  Results are shown 
in Table 4 – 22.  Spinal and femoral BMD means were not significantly different for 
participants based on their family history of osteoporosis. 
Table 4 – 22 
ANOVA of Family History of Osteoporosis on Spinal and Femoral BMD 
 
                                                                                                      F    p 
Family History of Osteoporosis (Spinal) 0.31     0.73 
Family History of Osteoporosis (Femoral) 1.11 0.33 
 
 57 
 
 Next, pairwise correlations were conducted on the continuous predictor variables:  
BMI, length of time on oral contraceptives, age, and average calcium intake, with spinal 
BMD and femoral BMD.  The results are shown in Table 4 – 23.  These results show 
that BMI category (BMI) and physical activity were significantly correlated with spinal 
BMD and femoral BMD.  Length of time on oral contraceptives, age, and average 
calcium intake were not significantly correlated with spinal BMD and femoral BMD.  
Table 4 – 23 
Pairwise Correlations Between Spinal and Femoral Bone Mineral Density, Body Mass Index, Length of 
Time on Oral Contraceptives, Age, Physical Activity, and Average Calcium Intake 
 
 
 
 A secondary purpose of this study was to evaluate the difference in osteoporosis 
knowledge among college-aged African-American women and Caucasian women.  
Results of t-test are shown in Table 4 – 24.  According to t-test results, osteoporosis 
knowledge between African-American and Caucasian women was significantly different.  
Caucasian women were more knowledgeable of osteoporosis than African-American 
women.   
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Table 4 – 24 
Osteoporosis Knowledge Between African-American and Caucasian Women 
  
n 
Mean 
Score 
Mean Difference  
95% Confidence Interval 
 
p 
Race 
    African American 
    Caucasian 
 
50 
51 
 
15.94 
14.36 
1.58 0.23, 2.93 0.02 
      
 
 
Multivariable Findings 
 Multiple linear regression was performed to determine which predictor variables 
were significant in predicting femoral and spinal BMD.  The multiple regression 
normality assumption was tested using the Shapiro-Wilk test.  The Shapiro-Wilk statistic 
was non-significant (p = 0.53) which indicates that the normality assumption was not 
violated.  The residual plots were examined for linearity and homogeneity of variance.  
The plots demonstrated a linear relationship; therefore the linearity assumption was not 
violated.  The standardized residuals were examined to search for outliers.  None of the 
standardized residuals were greater than three standard deviations from the mean; 
therefore, no outliers were present.  Based on these results, it was determined that the 
use of multiple linear regression was appropriate. 
 Multiple regression was conducted to determine which predictor variables predict 
spinal BMD and which of the independent variables predict femoral BMD.  Multiple 
regression results indicate that BMI and total hours of exercise are significant predictors 
of femoral BMD as well as spinal BMD.  The results from the regression analysis for 
spinal BMD are presented in Table 4 – 25.  Accordingly, the model for predicting spinal 
BMD is as follows: Y = -2.388 + 0.073 (BMI) + 0.071 (hours of exercise).   
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 The final regression model is significant in predicting 14.9% (R2=0.149) of the 
variance in spinal BMD (p = 0.017).  Race, family history of osteoporosis, oral 
contraceptive  use, calcium intake, and age were not significant predictors of spinal 
BMD.  The model summary and the ANOVA summary table are shown below in Table 4 
– 26 and Table 4 – 27, respectively. 
 
 
Table 4 – 25 
 
Multiple Regression Results for Spinal Bone Mineral Density 
 
 
 
 
 
Table 4 – 26 
 
Model Summary for Spinal Bone Mineral Density 
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Table 4 – 27 
 
ANOVA Summary Table for Spinal Bone Mineral Density 
 
 
 
 
Table 4 – 28 
 
Multiple Regression Results for Femoral Bone Mineral Density 
 
 
The results from the regression analysis for femoral BMD are presented in Table 
4 – 28.  Accordingly, the model for predicting femoral BMD is as follows:   Y = -1.111 + 
0.078 (hours of exercise) + 0.056 (BMI).  The final regression model is significant in 
predicting 13.1% (R2=0.131) of the variance in femoral BMD (p = 0.010).  As with spinal 
BMD, race, family history of osteoporosis, oral contraceptive  use, calcium intake, and 
age were not significant predictors of femoral BMD.  The model summary and the 
ANOVA summary table are shown below in Table 4 – 29 and Table 4 – 30. 
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Table 4 – 29 
 
Model Summary for Femoral Bone Mineral Density 
 
 
 
 
Table 4 – 30 
 
ANOVA Summary Table for Femoral Bone Mineral Density 
 
 
 
Summary of Results and Hypotheses 
 The results of the null hypotheses tested are discussed in the following 
paragraphs.  HO1 stated that African-American women’s bone mineral density level 
would not be significantly different from Caucasian women’s bone mineral density 
among low, normal, and high weight categories groups.  ANOVA results showed that 
there was no significant difference in the mean spinal and femoral BMD (p = 0.23 and  
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p = 0.15, respectively) between African-American and Caucasian women.  Furthermore, 
there was no significant difference in the mean spinal and femoral BMD of African-
American and Caucasian women based on the interaction between race and weight 
category  (p = 0.81 and p = 0.94, respectively).  Therefore there was no significant 
difference between the mean spinal and femoral BMDs of African-American and 
Caucasian women in the low-weight category; there was no significant difference 
between the mean spinal and femoral BMDs of African-American and Caucasian 
women in the normal-weight category; and there was no significant difference between 
the mean spinal and femoral BMDs of African-American and Caucasian women in the 
high-weight category.  Therefore, HO1 failed to be rejected. 
 HO2 stated that women with high BMIs (high weight) would not have significantly 
different bone mineral density than women with low BMIs (low weight) regardless of 
race.  ANOVA results showed that both spinal and femoral BMDs were significantly 
different (p = 0.001 and p = 0.01, respectively) across BMIs.  Bonferroni post-hoc 
results for femoral BMD showed that the femoral BMD of participants with a low BMI 
was significantly different from the femoral BMD of participants with a high BMI  
(p = 0.01).  Bonferroni post-hoc results for spinal BMD showed that the spinal BMD of 
participants with a low BMI was significantly different from the spinal BMD of 
participants with a high BMI (p = 0.003).  It also showed that the lumbar spine BMD of 
individuals with a normal BMI was significantly different from spinal BMD of individuals 
with a high BMI (p = 0.01).  Therefore, HO2 was rejected. 
 HO3 stated that women who have inadequate intake of calcium would not have a 
significantly different BMD than women who have an adequate intake of calcium.  The 
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results of t-test analyses also showed that the mean spinal and femoral BMDs of those 
who had an adequate intake of calcium were not significantly different from those who 
had an inadequate intake of calcium (p = 0.71 and p = 0.48, respectively).  Therefore, 
HO3 failed to be rejected. 
 HO4 stated that BMD would not be significantly different in women who currently 
engage in regular physical activity in comparison to women who do not engage in 
regular physical activity regardless of ethnicity.  Results of t-test analyses also showed 
that those who currently engaged in an adequate amount of physical activity did not 
have significantly different spinal or femoral BMDs from those who did not currently 
engage in adequate amounts of physical activity (p = 0.73 and p = 0.83, respectively).  
Therefore, HO4 failed to be rejected. 
 HO5 stated that women who participated in high school sports would not have 
significantly different BMD values from women who did not participate in sports during 
high school regardless of ethnicity.  Results of t-test analyses showed that those who 
participated in high school sports did not have significantly different spinal or femoral 
BMDs from those who did not participate in sports during high school (p = 0.56 and  
p = 0.60, respectively).  Therefore, HO5 failed to be rejected. 
 HO6 stated that length of time on oral contraceptives would not be significantly 
related BMD.  Pairwise correlations showed that length of time on oral contraceptive 
was not significantly related to spinal BMD (p = 0.42) or femoral BMD (p = 0.35).  
Analyses by t-test also showed that those who took oral contraceptives did not have 
significantly different spinal or femoral BMD (p = 0.21 and p = 0.12, respectively) from 
those who did not take oral contraceptives.  Therefore, HO6 failed to be rejected. 
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 HO7 stated that BMD values would not be significantly different in women who are 
more knowledgeable of osteoporosis in comparison to those who are less 
knowledgeable.  Results of t-test analyses showed that those who were more 
knowledgeable about osteoporosis did not have significantly different spinal or femoral 
BMDs from those who were less knowledgeable about osteoporosis (p = 0.64 and  
p = 0.83, respectively).  Therefore, HO7 failed to be rejected. 
 HO8 stated that BMD values would not be significantly different between African 
American and Caucasian women.  Analyses from t-test also showed that African-
Americans’ mean spinal and femoral BMD was not significantly different from 
Caucasians’ mean spinal and femoral BMD (p = 0.42 and p = 0.26, respectively).  
Therefore, HO8 failed to be rejected. 
 The secondary purpose of this study is to examine differences in osteoporosis 
knowledge between African-American and Caucasian participants.  According to t-test 
results, there is a significant difference in osteoporosis knowledge between African-
American and Caucasian participants (p = 0.02).  Caucasians are more knowledgeable 
about osteoporosis than African-Americans. 
 The research question for this study was: What variables account for the 
variance in BMD among African-American and Caucasian college-aged women?  
Results of multiple linear regression showed that after including the predictor variables 
age, physical activity, race, calcium intake, contraceptive use, family history of 
osteoporosis, and BMI in the regression equation, only body mass index and total 
exercise significantly predicted spinal BMD (p = 0.001 and p = 0.017, respectively).  
Body mass index and total exercise also significantly predicted femoral BMD (p = 0.010 
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and p = 0.007, respectively).  The final regression models were significant in predicting 
13.1% (R2=0.131) of the variance in femoral BMD (p = 0.010) and 14.9% (R2=0.149) of 
the variance in spinal BMD (p = 0.017).  
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Chapter V 
Discussion 
The primary purpose of this research was to explain the variance in BMD in 
African-American and Caucasian college-aged women.  A secondary purpose was to 
evaluate the differences in osteoporosis knowledge among college-aged African-
American and Caucasian women.  This chapter is divided into the following sections:  
(1) discussion of results, (2) additional findings, (3) recommendations, and (4) future 
research. 
According to K. Khan et al. (2004), approximately 15% of premenopausal women 
have low bone mineral density.  In this study of premenopausal women, 38.6% had low 
spinal BMD; and 7.9% had low femoral BMD.  Although some premenopausal women 
have low bone mineral density, the U.S. Preventive Services Task Force (as cited by 
USDHHS, 2004) does not recommend routine bone density testing for women until the 
age of 65.  The Task Force also recommends testing starting at the age of 60 for 
women who are at high risk for osteoporosis having a body weight less than 70 kg or 
having a lack of hormone replacement therapy.  
Given that it is possible for premenopausal women to have low bone mineral 
density, the researcher sought to identify factors that are responsible for determining 
BMD in African-American and Caucasian premenopausal women.  The predictor 
variables included in the model were age, physical activity, race, calcium intake, 
contraceptive use, family history of osteoporosis and BMI.  These variables are risk 
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factors for low bone mineral density.  The outcome variables, non-dominant femoral 
BMD and spinal BMD, were measured using a Hologic Delphi-W DEXA machine.   
 
Discussion of Results 
Finding no racial differences across BMI groups was an unprecedented finding 
because numerous studies show that African-American women consistently have higher 
BMDs when compared to their Caucasian counterparts ((Barrett-Connor et al., 2005; 
USDHHS, 2004; Finkelstein, 2002; NIH, 2001; Ettinger et al., 1997).  Due to previous 
research findings, one would expect that African-American women would consistently 
have higher BMDs than Caucasian women across each BMI category.  This, however, 
is not what the present study found.  It is possible that the higher prevalence of past and 
present use of Depo-Provera among African-American participants eliminated the racial 
differences that would typically be seen in this age group.  In the present study, 18% of 
African-Americans reported past or current Depo-Provera use in comparison to 2% of 
Caucasian participants.  Depo-Provera, a contraceptive which is injected 
intramuscularly, can cause a decline in femoral and spinal BMD (Walsh et al., 2008; 
Clark et al., 2004). 
 A number of studies show that weight status affects BMD (Coin et al., 2000; 
Rollins, Imrhan, Czajka-Narins, and Nichols, 2003; Young et al., 2001; and Wang et al., 
2005).  In the present study 43.6% of individuals who were classified as having a low 
BMI also had low spinal BMD; and 75% of those who had a low BMI also had low 
femoral BMD.  As a matter of fact, being thin and/or having a small frame is listed as 
one of the risk factors for low bone mass (Amonkar and Mody, 2002; NOF, 2008), 
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meaning that a larger frame or higher weight would be associated with a higher bone 
density.   
 The present study found no significant difference between the BMDs of women 
who had an inadequate intake of calcium and those who had an adequate intake of 
calcium is a very interesting finding.  This is interesting because, historically, low 
calcium intake has been listed as a risk factor for osteoporosis (NOF, 2008).  
Additionally, studies show that calcium intake plays a significant role in determining 
bone density (Harris et al., 2003; Gourlay and Brown, 2004; Heaney, 2001; and Prince 
et al., 2006).  Other studies, however, show that calcium intake is not important in 
determining BMD (Michaelsson, Melhus, Belloco, and Wolk, 2003; and Wallace and 
Ballard, 2002).  It is possible that no significant differences were seen between the 
spinal and femoral BMDs of women who had an adequate intake of calcium versus 
women who had an inadequate intake of calcium because this study only examined 
current calcium intake and not calcium intake over the life span. 
 Bainbridge, Sowers, Lin, and Harlow (2004) examined risk factors for low BMD in 
Caucasian women ages 22 to 44.  They found that current physical activity is not related 
to BMD.  When participants in the present study were categorized into two groups--
those who met the physical activity requirements and those who did not--t-test results 
show no significant difference in spinal or femoral BMDs between the two groups.  
However, when spinal and femoral BMD were regressed on hours of current physical 
activity, it was a significant predictor of both spinal and femoral BMD.  This finding is 
consistent with Ford et al. (2004), whose study included 157 women, aged 18 to 39.  
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They found that current physical activity was significantly associated with spinal BMD  
(p = 0.004).   
The American College of Sports Medicine and The American Heart Association 
recommends at least 30 minutes of exercise on not less than five days of the week for 
adults aged 18 to 65 years (Haskell et al., 2007).  Only 21.8% of the participants in this 
study met these requirements.  Furthermore, 33.7% of this sample reported no physical 
activity.  The latter finding is consistent with the findings of Wallace (2002), who found 
no physical activity reported in 30% of the subjects in a similar age group to that of the 
present study.  Total hours of exercise were significantly different between Caucasians 
and African-Americans.  Caucasians reported spending an average of 7.69 hours per 
week engaged in physical activity in comparison to an average of 3.36 hours per week 
reported by African-Americans.  Caucasians were also more likely to meet exercise 
requirements in comparison to African-Americans (29.4% versus 14%).  The lack of 
physical activity is a possible reason why low spinal BMD was so prevalent in this 
sample. 
 Asking participants about their high school sports participation was used to 
determine physical activity during teenage years.  The typical age of a high school 
student is 15 to 18 years.  Physical activity during the teenage years is deemed 
important due to the fact that the typical female accumulates 40 to 60 percent of their 
bone mass during these years (Lloyd et al., 2000).  Therefore, physical activity during 
this crucial time can have an effect on BMD.  Studies have found high school sports 
participation to be a factor affecting BMD among this age group (Ford et al., 2004; 
Bainbridge et al., 2004).  For example, Ford et al. (2004) found that women between the 
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ages of 18 and 39, who did not participate in high school sports, were seven times more 
likely to have low BMD in comparison to those who were involved in sports during high 
school.  High school sports participation was assessed by the question, “Did you 
participate in sports in high school?” with the answer choices being “Yes” and “No.”  It is 
possible that the present study did not find significant differences in BMD between those 
who participated in high school sports and those who did not as did previous because of 
racial differences in the samples.  Both Ford et al. (2004) and Bainbridge et al. (2004) 
had samples that were predominantly Caucasian, whereas the present study had an 
even distribution of African-American and Caucasian women. 
 Data, in regards to the affect that oral contraceptive use has on BMD, is 
equivocal.  There are some studies that show that oral contraceptive use has a 
beneficial effect on BMD in a similar age group to the present study (Pasco et al., 2000; 
Kleerekoper, Brienza, Schultz, and Johnson, 1991); while other studies show that oral 
contraceptive use has a negative effect on BMD (Prior et al., 2001; Shoepe and Snow, 
2005; Egan, Reilly, Giacomoni, Redmond, and Turner, 2006).  Additionally, studies 
show that oral contraceptives either have no effect on BMD or that the results of the 
effect of oral contraceptives on BMD are inconclusive (Reed et al., 2003; Cobb et al., 
2007).  The average length of time on oral contraceptives for participants in this study 
was 2.5 years (SD ±2.35 years).  It is possible that an effect on BMD from oral 
contraceptive use was not seen in this study due to participants not being on oral 
contraceptives long enough to see an effect.  It is believed that a number of years of 
oral contraceptive use in premenopausal women are needed before seeing a significant 
effect on BMD (Kuohung, Borgatta, and Stubblefield, 2000).  Kleerekoper et al. (1991) 
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found that the greatest protection against low BMD was seen in pre- and 
postmenopausal women who had taken oral contraceptives for 10 or more years. 
 A little over half of the participants (56.4%) answered approximately 60% of 
osteoporosis knowledge questions correctly.  These results are similar to that of 
Anderson, Auld, and Schilitz (1996) who assessed the osteoporosis knowledge of 
women in a similar age group (aged 18 to 35 years).  In the present study, over 90% of 
the participants knew that having a diet low in dairy products and not engaging in 
regular physical activity put them at increased risk for osteoporosis.  These findings are 
similar to that of other studies in a similar age group to the present study (Ford, Bass, 
and Keathley, 2007; Kasper, Peterson, and Allegrante, 2001).  Unfortunately, 
knowledge alone is often not enough to cause a behavior change (Wallace, 2002).  
Furthermore, studies show that osteoporosis prevention behaviors in women are not 
influenced by their osteoporosis knowledge (Terrio and Auld, 2002; Kasper, Peterson, 
and Allegrante, 2001).  This can possibly explain why no significant difference in BMD 
as a result of more osteoporosis knowledge versus lack of knowledge was observed in 
the present study.  Although participants were knowledgeable about osteoporosis that 
did not translate to them engaging is osteoporosis-preventative behaviors. 
 
Other Findings 
 Only 5.9% of this sample reported being a current smoker.  Furthermore, 
Caucasian women were more likely to be a current smoker in comparison to African 
American women (9.8% versus 2%).  The percentage of current smokers in the present 
study was low compared to 22.5% smoking rate among women in Mississippi ages 18 
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years and older and the 28.8% smoking rate among individuals in Mississippi between 
the ages of 18 and 35 (MMWR, 2006).  Therefore, our sample may have been drawn 
from a healthier population. 
Family history of osteoporosis was determined by self-reported information 
obtained from two questions:  “Was your biological mother or grandmother ever told by 
a doctor that they had osteoporosis, sometimes called thin or brittle bones?” and “Did 
your biological mother or grandmother ever fracture her hip?”  Participants chose from 
the options of “Yes,” “No,” or “I don’t know.”  It was reported by one African-American 
participant that her biological mother or grandmother was diagnosed with osteoporosis; 
whereas 17 (31.4%)  Caucasian participants reported that their biological mother or 
grandmother had been diagnosed with osteoporosis.  Although only one African-
American participant reported having a family history of osteoporosis, three African-
American participants reported having a family history of fracture.  There are three 
possible reasons as to why the number of African-Americans reporting a family history 
of hip fractures is higher than the number of African-Americans reporting a family history 
of osteoporosis.  One reason could be because all fractures are not necessarily 
osteoporotic fractures; so the hip fractures that occurred could have been due to factors 
other than osteoporosis.  Secondly, it is possible that the family member who suffered 
the fracture was unaware of her osteoporotic-status.  Thirdly, 18% of African-American 
participants reported not knowing their family history of osteoporosis.  Therefore, it is 
possible that the participant did not know the osteoporotic-status of the family member 
who suffered the hip fracture. 
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Absence or presence of consumption of breast milk as a child was determined 
through the question:  “When you were a baby, were you breastfed?”  The response 
options were “Yes,” “No,” and “I don’t know.”  It was reported by 45.5% of the 
participants that they were breastfed as a child whereas 43.6% reported not being 
breastfed as a child; and 10.9% reported not knowing whether or not they were 
breastfed as a child.  Of the 45.5% who reported being breastfed as a child, only 11 
were African-American whereas 35 were Caucasian.  It is possible that the absence of 
being breastfed as an infant contributed to the presence of low BMD in this sample.  
Jones, Riley, and Dwyer (2000) found that BMD was higher in 8-year-old children who 
were breastfed longer than 3 months in comparison to the formula-fed children.   
Data were obtained regarding childhood milk consumption through the question, 
“During your childhood, approximately how many servings of milk did you drink each 
day?”  The answer choices were “None,” “1 serving,” “2 servings,” “3 servings,” and “4 
or more servings.”  It was reported by 7.9% that they consumed no milk during their 
childhood; and 7.9% reported having 4 or more servings per day.  For the purposes of 
this study, one serving of milk is equivalent to one cup; therefore, those who reported 
having four or more servings of milk per day were in actuality reporting that they 
consumed four or more cups of milk per day.  There are 283.8 mg (1200mg/L) of 
calcium per cup of milk (Zhao, Martin, and Weaver, 2005).  If milk was their only source 
of calcium during childhood, this means that only 8 participants consumed the 
recommended amounts of calcium during childhood.  This finding is important because 
Kalkwarf, Khoury, and Lanphear (2003) found that women between the ages of 20 and 
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49 years who had a low intake of milk during childhood and adolescence also have a 
lower bone mass in adulthood. 
    
Recommendations  
It is clear from the number of participants in the study who are affected by low 
BMD that programs need to be established to encourage young women to engage in 
behaviors that will maximize their bone densities.  According to A. Khan (2006), 
premenopausal women should be encouraged to modify their lifestyles to improve their 
BMD.  It has been shown that physical activity, particularly weight-bearing exercises, 
help to improve BMD.  In this study, however, only 21.8% of the participants got the 
recommended amount of physical activity.  Furthermore, in this study Caucasians were 
more likely than African-Americans to meet the exercise requirements.  Since physical 
activity was significant in predicting bone mineral density in this study, programs that 
specifically target increasing physical activity among young women should be 
established.  Additionally, programs that target increasing the amount of physical 
activity among African-Americans should be established. 
 Although Caucasian women were more knowledgeable than African-American 
women regarding osteoporosis, overall, osteoporosis knowledge was lacking in this 
sample.  A little over half of the participants (56.4%) answered approximately 60% of 
osteoporosis knowledge questions correctly.  Although most participants were aware 
that lack of dairy products and lack of exercise put them at risk of osteoporosis, they 
were less aware of the specific types of foods that provide calcium and the specific 
types of exercises that improve bone health.  Therefore, programs need to be put in 
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place to not only increase knowledge about osteoporosis, but also to encourage 
implementation of bone building behaviors.   
 
Future Research 
 In this study, BMI was a significant predictor of both spinal and femoral BMD.  
Furthermore, participants in the low BMI category had significantly different mean 
femoral BMDs than individuals in the high BMI category; and participants in the low and 
normal BMI categories had significantly different mean spinal BMDs than individuals in 
the high BMI category.  Studies, however, have shown that the proportion of lean mass 
to fat mass has an effect on BMD (Wang et al., 2005; Young et al., 2001).  One of the 
limitations of the present study is not distinguishing between fat mass and lean mass, 
although these measurements were taken.  BMI was used rather than fat and lean 
mass to give physicians and the general public a more convenient way of determining 
risk for low BMD.  Therefore, future research should look more in-depth at the fat mass 
and lean mass of the individuals in this study to determine their contribution to the 
differences in BMD. 
 After including variables that affect bone mineral, only two, weight and physical 
activity, of the seven predictors were significant in predicting spinal and femoral BMD.  
Furthermore, these two significant predictors only accounted for 14.9% and 13.1% of 
the variance in spinal and femoral BMD, respectively.  It is possible that genetics 
accounts for, in part, the remaining unexplained variance.  According to Koller et al. 
(2000), up to 80% of the differences seen in peak BMD can be attributed to genetic 
factors.     
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Hormones, such as estrogen, possibly played a part in the remaining 
unexplained variance.  Early menarche has been shown to result in higher BMD in 
premenopausal women just as late menarche has been shown to result in lower BMD 
and increased risk of fracture in postmenopausal women (Chevalley, Bonjour, Ferrari, 
and Rizzoli, 2008).  These findings are due to the differences in duration of exposure to 
estrogen (Chevalley, Bonjour, Ferrari, and Rizzoli, 2008).  Data regarding age at 
menarche was collected for the current study but was not included as one of the 
predictor variables for the regression model.  Including an additional variable would 
have required at least an additional 10 participants.  Therefore, this variable was not 
included due to budgetary restraints.  A future study can examine the age at menarche 
for participants in the current sample to determine what affect, if any, this variable had 
on BMD values. 
  Another avenue for future research could include the replication of the current 
study in an older age group.  Racial differences were not observed in this study.  It is 
possible that racial differences in bone mineral density occur at a later age than that 
used in the current study.  This seems plausible seeing that women in the current age 
group have not reached peak BMD. 
 The restrictions in this sample cannot be discounted as attributing to the lack of a 
substantial amount of variance in BMD being found.  Since this sample was restricted 
regarding age and factors that place women at apparent risk for low BMD, the amount 
of variability was reduced.  Therefore, it is difficult for the current study to account for a 
substantial amount of variance due to the research design limiting the variability of the 
sample. 
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Conclusions: 
Contrary to what was hypothesized, race was not a significant predictor of spinal 
or femoral BMD.  Therefore, it is important for both African-American and Caucasian 
women alike to engage in osteoporosis-preventive behaviors.  If women between the 
ages of 18 and 30 are made aware of their low-BMD status, they can begin bone-
building activities before they reach peak bone mass.  This provides an opportunity to 
decrease risk for osteoporosis and related fractures later in life.  Women between the 
ages of 18 and 30 can also be encouraged to maintain a healthy body weight and be 
more physically active to potentially increase their spinal and femoral BMD. 
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INITIAL PHONE CONTACT WITH POTENTIAL SUBJECT  
 
STUDY:   A Comparison of Bone Mineral Density in African American and Caucasian College 
Women 
INVESTIGATORS:   ANDREA JOHNSON, MS & M. ALLISON FORD, PH.D 
 
 
Part 1: Subject Information (Part of PI’s confidential records – do not make hard copies of part 1) 
 
 
Name of investigator or study personnel:  _________________________________________________ 
 
 
Date of phone call:  ______/______/______  Time of phone call:  ______:______ 
 
 
How did the subject hear about the study (circle)? 
 
1. Flyer 
2. Class visit 
3. Other – Please specify _____________________________________________________ 
 
Verbal Informed Consent Process 
 
1. Verbal informed consent process completed (i.e. phone script on p. 2) (circle):     YES   -   NO  
 
2. Verbal consent obtained (circle):     YES   -   NO  Time:  ______:______ 
 
3. If answer to question 2 is NO, discontinue phone conversation with subject, otherwise proceed with question 
no. 4 
 
4. If answer to question 2 is YES, then record following information from the subject: 
 
a. Subject’s Fi rst Name:  ______________________________________ 
 
b. Age:  _________    
 
c. Race:________________ 
 
d. Assign subject ID ____________________________ 
 
Part 2: Phone Script 
 
Thank you for calling to find out more about our research study.  My name is {staff name}, and I am a researcher at 
the University of Mississippi. The main purpose of this research study is to investigate bone mineral density among 
African American and Caucasian college age females. A secondary purpose of this study is to test osteoporosis 
knowledge among African American and Caucasian college age women. The following information will be destroyed 
if you choose not to participate. At any point during this conversation if you answer “NO” to a question and would like 
to discontinue, no more questions will be asked and you will be deemed ineligible to participate.   
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If you decide to participate in the study, we will ask you to come in for 2 visits (~ 1 hour each).  During your 1st 
visit, you will complete an osteoporosis risk factor assessment, a 7-day physical activity recall instrument, 
and an osteoporosis knowledge questionnaire.  You also will be instructed on how to record your food 
intake for 2 weekdays and 2 weekend days.  On your 2nd visit, you will receive a DEXA scan (similar to 
an x-ray) to measure bone mineral density. You will also provide me with your 4-day food record and 
verify the information contained in your food record. Do you think you might be interested in participating in 
that study? 
 
 {If answer is “NO”, discontinue conversation}:  Thank you very much for calling. 
 
 {If answer is “yes”, proceed}:  O.K. 
 
 
 
Before enrolling people in this study, we need to determine if you are eligible.  And so what I would like to do now is 
ask you a few questions about your current and past health condition.  Also, I would like to let you know tha t the 
information that I receive from you by phone and reveals your name or identity will be strictly confidential and will be 
kept securely.  The purpose of these questions is only to determine whether you are eligible for our study. Remember 
that your participation is voluntary. 
 
 
Do I have your permission to ask you these questions and record your answers? 
 
{If answer is “NO”, discontinue conversation}:  Thank you very much for calling. 
 {Record answer and time in part 1 / no.2} 
 
 {If answer is “YES”, proceed}:  O.K. 
 {Record answer and time in part 1 / no.2 and proceed with part 1 / no. 4 and part 3) 
 
 
Part 3: Eligibility Criteria / Phone screening conducted if answer to question no. 2 in part 1 is YES 
 
 
• Date of phone screening: ______/______/______   
 
• What is your height___________inches 
 
 
• What is your weight___________lbs 
 
BMI TO BE CALCULATED HERE FOR EXCLUSION CRITERIA:  
 
Formula: weight (lb) / [height (in)]2 x 703  
Calculation: [weight (lb) / height (in) / height (in)] x 703 
Calculate BMI by dividing weight in pounds (lbs) by height in inches (in) squared and multiplying by a conversion 
factor of 703.  
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Example: Weight = 150 lbs, Height = 5’5” (65") 
Calculation: [150 ÷ (65)2] x 703 = 24.96 
BMI:______________________ 
**NOTE: Must be less than 18.5 or between 25 and 30 in order to continue if not---Thank you for 
showing interest in our research study.  At this time, you are not eligible for our study.  
• Ask the participant the following questions:   
 If any participant answers YES to any of these questions (UNLESS NOTED ON THE 
QUESTION), they will not be eligible for this study.  
 
o Have you ever been diagnosed wi th Cushings Disease?  YES - NO 
 
o Have you ever been diagnosed wi th Celiac Disease?  YES - NO 
 
o Have you ever or do you currently smoke cigarettes?  YES - NO 
 
 
 If yes-> How many cigarettes per day do you smoke           __________ 
(NOTE: There a typically 20 cigs per pack)  
(NOTE WE WILL NOT EXCLUDE ALL SMOKERS JUST THOSE WHO SMOKE MORE THAN 
A HALF PACK OF CIGARETTES PER DAY) 
 
 
o Is your age between 18 and 30 years       YES - NO 
NOTE: PARTICIPANT MUST answer YES 
 
o Have you ever been diagnosed wi th anorexia or bulimia  YES  - NO 
 
 
o Have you ever taken synthetic glucocorticoids-also called 
 steroids including cortisone, prednisone?   YES - NO 
 
 If yes-> have you taken these for longer  
                    Than 6 weeks    YES - NO 
 
o Have you ever taken any of the following medications? 
 
Anti-convulsants    YES - NO 
 
Thyroid hormone YES - NO 
 
Antacids that contain aluminum     YES - NO 
 
Methotrexate -- used to treat a variety of cancers,                                    YES - NO 
 immune disorders, and resistant arthritic conditions 
 
Cyclosporine A -- used in organ transplantation and for the 
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 treatment of some diseases of the immune system  YES - NO 
 
Gonadotropin Releasing Hormone (GnRH) Analogues –  YES - NO 
used in the long-term treatment of Endometriosis 
 
Heparin -- used to prevent blood clotting                                                   YES - NO 
 
Cholestyramine  -- used to contro l blood cholesterol levels                        YES - NO 
 
Depo-Provera                                                                                             YES - NO 
 
 
 
• Do you have any questions for me?      YES - NO        
If yes, summarize subject’s concerns/questions: 
 
_________________________________________________________________________________________ 
 
 
_________________________________________________________________________________________ 
 
 
• Subject’s questions and concerns were answered (circle):         YES - NO        
 
 
 
• Based on phone screening, is subject eligible to participate in the study?  YES - NO        
If YES, proceed with part 4.   If NO, please destroy all subject information. 
 
 
• As determined through this phone screening, you are eligible to participate, would you be interested in 
participating:        YES    -    NO 
 
• Now that we have determined you are eligible to participate, I would like to record your contact information to 
contact you for testing purposes and scheduling: 
 
Subject’s Phone Number:  ______________________________________ 
Alternate Phone Number: ______________________________________ 
Subject’s Email Address: ______________________________________ 
 
 
*********END OF Part 3: Eligibility criteria / Phone screening********* 
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Part 4:  Subject Availability for Testing 
 
Time MON TUES WED THURS FRI 
Morning  
 
    
Afternoon  
 
    
 
Other Information provided to subject: 
• For testing, please wear  
o Pants 
o Comfortable clothing that does not contain metal objects such as buttons and zippers or 
under wire bras.  
• You will be asked to consent to a urine pregnancy test (under 55 and/or have had a hysterectomy) 
• Directions if needed 
• Schedule time or  will be contacted to schedule a time 
 
Additional notes:  _____________________________________________________________________________ 
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Please answer to the best of your knowledge. 
   
 
1. Was your biological mother or grandmother ever told by a doctor they had 
osteoporosis, sometimes called thin or brittle bones? 
 
a. Yes 
b. No 
c. I don’t know 
     1a. Has a doctor ever told you that you have osteoporosis, sometimes  
called thin or brittle bones?  
 
a. Yes 
b. No 
 
1b. If your doctor has told you that you have osteoporosis, have you   
   ever taken any medication other than calcium supplements for this    
   disease? 
 
a. Yes 
b. No 
c. I don’t know 
 
2. Did your biological mother or grandmother ever fracture her hip? 
 
a. Yes 
b. No 
c. I don’t know 
 
3. When you were a baby, were you breastfed? 
 
a. Yes 
b. No 
c. I don’t know 
 
4. Have you ever been on a high protein diet (Atkins, South Beach, etc)? 
 
a. Yes 
b. No (if No, skip to #6) 
 
5. How long have you been on this diet (or how long were you on this diet)? 
 
a. more than 1 year 
b. 10-12 months 
c. 7-9 months 
d. 4-6 months 
e. 1-3 months 
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6. During your childhood, approximately how many servings of milk did you    
          drink each day?  
 
a. None (0 servings) 
b. 1 serving each day 
c. 2 servings each day 
d. 3 servings each day 
e. 4 or more servings each day 
  
7. In general, do you take the stairs or the elevator? 
 
a. Stairs 
b. Elevator 
 
The next questions ask about your background. 
 
8. When is your birthday? (MM/DD/YY)      
 
 
9. Which of the following best describes your ethnic group? 
 
a. 1 = Non-Hispanic White 
b. 2 = Non-Hispanic African American 
c. 3 = Asian American or Asian 
d. 4 = American Indian or Alaska Native 
e. 5 = Native Hawaiian/Pacific Islander 
f. 6 = Hispanic—country of origin___________________ 
g. 7 = Other  
 
10. Does anyone who lives with you smoke cigarettes in the home? 
 
a. Yes 
b. No (if No, skip to #12) 
 
11. Total number of persons who smoke cigarettes in the home. 
 
      a. 0 
      b. 1 
      c. 2 
      d. 3 
      e. 4+ 
 
12. Do you smoke? 
  
 a. Yes 
 b. No (if No, skip to #14) 
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13. If you have ever smoked cigarettes, how long did you smoke? 
  
a. I have never smoked cigarettes 
b. less than 1 year 
c. less than 3 years 
d. less than 5 years 
e. less than 10 years 
f. greater than 10 years 
 
14. How many alcoholic beverages do you generally consume in a setting? 
 
a. 0 
b. 1 
c. 2 
d. 3 
e. 4+ 
 
15.  Have you had a period in the last 12 months? 
 
       a. Yes 
       b. No 
 
16. Have you ever been amenorrheic (lost your menstrual cycle for any reason,  
other than pregnancy for longer than 3 months)? 
 
       a. Yes 
       b. No 
 
 
 
17. Have you ever taken or used estrogen or female hormones in any form (i.e.  
pills, vaginal cream, suppositories, injections or skin patches?  
 
       a. Yes 
       b. No 
 
18. How old were you when you first took or used the estrogen or female  
hormones? _____years 
 
19. Have you ever taken birth control pills for any reason? 
 
a. Yes 
b. No 
 
20. How long altogether have you or did you take birth control pills? _________ 
 
21. Have you ever had the Depo-Provera shot? 
 
a. Yes 
b. No (if No, skip to #24) 
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22. If you are currently taking, how long have you been taking the Depo- 
Provera shot? _______ 
 
23. If you are currently not taking the Depo-Provera shot, but have in the past,  
how long did you consistently take it? ________________ 
 
24. How many live births have you had?  
 
a. I have never had a live birth (if never, skip to #29) 
b. 1 live birth 
c. 2 live births 
d. 3 live births 
e. 4 live births 
f. 5 live births 
g. 6 live births 
h. More than 6 live births  
 
25. If you have had a live birth, how many did you have before age 30 and after age 
30?      
      _____ before age 30 
 _____ after age 30 
 
26. Approximately how much weight did you gain with each live birth  
pregnancy? 
 
1st pregnancy ________lbs   4th pregnancy ________lbs 
 
2nd pregnancy ________lbs   5th pregnancy ________lbs 
 
3rd pregnancy ________lbs   6th pregnancy ________lbs 
 
 
27. Did you breastfeed any of your children?     Yes  No 
 
 
28. If yes, how many of your children have you breastfed? _________ 
 
29.  Education: _______years (total # years in college) 
 
30.  College Major:  ____________________________________________ 
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Figure 1:  Comparison of Low and Normal Femoral Bone Mineral Density on Mean Body Mass Index, 
Total Hours of Exercise, Total Grams of Calcium, and Length of Time on Oral Contraceptives  
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Figure 2:  Comparison of Low and Normal Spinal Bone Mineral Density on Mean Body Mass Index, Total 
Hours of Exercise, Total Grams of Calcium, and Length of Time on Oral Contraceptives  
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Figure 3:  Comparison of Caucasians and African – Americans with Low Femoral Bone Mineral Density 
on Mean Body Mass Index, Total Hours of Exercise, Total Grams of Calcium, and Length of Time on Oral 
Contraceptives 
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Figure 4:  Comparison of Caucasians and African – Americans with Low Spinal Bone Mineral Density on 
Mean Body Mass Index, Total Hours of Exercise, Total Grams of Calcium, and Length of Time on Oral 
Contraceptives 
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Figure 5: Comparison of Percentages of Correct Answers Between African-Americans and Caucasians 
on Osteoporosis Knowledge Test.  Note: Numbers around the graph corresponds to each question on the 
Osteoporosis Knowledge Test. 
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